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1. Introduction 
1.1 Genomics to Proteomics 
 Genomics, the study of the genomic composition of organisms through DNA 
mapping and DNA sequencing, has opened the door for the study of the gene 
products, the proteins that are encoded in the genes, and this derivative study has been 
defined as proteomics (1,2). As a better understanding of these fields developed 
through time, people involved in this field have learned that unlike genomics where 
DNA is chemically and physically more stable, work load is scalable and where 
experimental techniques are well established, proteomics studies present the 
researcher with a very challenging task because proteins are very dynamic and are 
constantly undergoing post-translational modifications induced environmentally or 
due to different cellular processes (1,3). Proteomics no longer focuses simply on the 
gene products, but at the same time, tries to understand what happens to the proteins 
after translation, protein function, protein-protein interactions and the post-
translational changes that proteins undergo in-vivo, greatly diversifying the proteome 
by orders of magnitude (1,3). Indeed, it is very hard to keep up with the modifications 
that come after translation in order to serve specific functions, or are simply victims 
of their environment. For the most part, enzymatic post-translational modifications 
(PTMs) play an important role in cellular function, however, non-enzymatic PTMs 
are mostly results of the environment, which can be detrimental to the life of the 
protein because they may cause the loss of function (4). Most amino acids may 
undergo change, however, for the purposes of the work described in this thesis, we 
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will focus on the amino acid Tyr. Some enzymatic reactions that Tyr may undergo are 
phosphorylation, very important in signaling transduction, and halogenation, very 
important for the synthesis of hormones (5). Non-enzymatic PTMs are mainly due to 
oxidation (4) and an example of this would be protein Tyr nitration, which is the main 
focus of this dissertation. 
1.2 Tyrosine Nitration  
The post-translational modification of tyrosine to nitrotyrosine (3-NY) 
represents a marker, as discussed earlier, for protein oxidation, which in turn is a 
modification associated with various pathologies (6,7) and the process of biological 
aging (8-13). Protein nitration occurs as a result of oxidative stress, which leads to the 
oxidative metabolism of nitric oxide (NO), resulting in the formation of reactive 
nitrogen species (RNS) (10,14). Reactive oxygen species (ROS) are also generated as 
normal byproducts of oxidative metabolism (15), where estimates show that 2-5% of 
the oxygen flux through the mitochondrial electron transport chain suffers conversion 
into superoxide anion radical (O2-.) (16). Superoxide reacts with nitrogen monoxide 
(NO) to form peroxynitrite (ONOO-) (17), a powerful oxidant of aromatic and 
organosulfur compounds (18,19). In addition, ONOO- is able to nitrate Tyr via 
multiple reaction mechanisms, either via a direct reaction with Tyr (20,21), via 
catalysis by transition metals (14,19,21), or through the proton or CO2-assisted 
formation of nitrogen dioxide (.NO2) (20-23).  
In biological systems, NO and superoxide coexist in a delicate balance, 
where even slight variations in the concentrations of these species dictate whether 
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oxidation or nitrosation pathways will be followed (24). The relative levels of 
superoxide have an effect on the levels of nitric oxide due to the diffusion–controlled 
reaction between NO and superoxide to form ONOO- (17,25). Superoxide dismutase 
(SOD) regulates the levels of superoxide and, therefore, has the potential to regulate 
redox-dependent signaling pathways through modulation of the effective levels of NO, 
superoxide, H2O2 and ONOO-. The relative amounts of these species, in turn, control 
the levels of nitrosating species, such as N2O3, or oxidizing/nitrating species, such as 
ONOO- (26). Disruption of the delicate balance between NO and superoxide leads to 
a so-called “nitroso-redox imbalance”, which may cause pathological conditions such 
as heart failure (27). 
While protein nitrosation can be reversed chemically, protein nitration leads 
to a chemically stable protein modification. Hence, the accumulation of nitrated 
proteins in tissue may define the phenotype of biological aging or of any pathology. 
The knowledge of specific protein nitration sites represents the ultimate goal for a 
correlation between protein modification and protein structure and function.  This can 
be illustrated by the targeted purification and analysis of specific nitrated proteins 
from tissue, such as SERCA. Here, biological aging leads to the selective nitration of 
the slow-twitch skeletal and cardiac muscle isoform SERCA2a nitrated at Tyr294 and 
Tyr295, which can be linked to the loss of enzyme activity (28-31). Other proteins 
studied to similar functional detail include manganese superoxide dismutase 
(MnSOD) (32,33), prostacyclin synthase (34), and actin (35).  
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1.3 Role of Protein Tyr Oxidation in Redox Signaling 
 There is compelling evidence that the intracellular redox environment is 
directly related to the actions of protein kinases (responsible for phosphorylation) and 
phospatases (responsible for dephosphorylation), which play a major role in the 
signaling pathways that regulate cell cycle, cell survival, cell proliferation and cell 
adhesion (36). Within the past decade, compelling evidence has been accumulated for 
the role of protein thiol oxidation and protein Tyr nitration as regulators of protein 
Tyr phosphorylation (36), or the opposite, where protein Tyr 
phosphorylation/dephosphorylation may play a role in protein Tyr nitration (37).  
Protein Tyr phosphorylation only represents <<1% of the total phosphorylated 
proteome, however, it has been shown to play a major role in the cell signaling 
pathways (36). Therefore, maintenance of a well balanced redox environment is 
essential for the health of an organism. Levels of ROS and RNS are kept in check by 
protein and non-protein reducing agents such as superoxide dismutase (SOD), 
catalase and glutathione (GSH) peroxidase (36). 
1.4 Mass Spectrometry in Proteomics Research 
 The most essential tool in proteomics is mass spectrometry, and therefore, 
most technological advancements have been done for this technique. However, mass 
spectrometry also has its limitations and using this technique alone is often not 
enough for identification and characterization of proteins and as a result, it is used in 
conjunction with other techniques such as immunoprecipitation, immunoblotting, 1D 
and 2D gel electrophoresis, chromatography, isotopic chemical tagging (4,38-41), 
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mainly as pre-fractionation techniques to reduce sample complexity. The use of 
different techniques may vary according to the goal of the proteomic study. The anti-
body based techniques for example, are most essential for identification and 
confirmation of specific PTMs, i.e., protein Tyr nitration. 
 Mass spectrometry has been accomplished by the extensive protein database 
made available thanks to the efforts of the field of genomics. The instrumentation 
used for mass spectrometry analysis is comprised of an ion source, mass analyzer and 
a detector. The most common ion sources used for proteomics studies are matrix 
assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) and 
the most common mass analyzers are ion traps, time of flight (TOF), quadrupole time 
of flight (QTOF), and Fourier transform ion cyclotron (FT-MS), which essentially 
differ in sensitivity, resolution and mass accuracy (40). Depending on the experiment, 
ion traps are usually good for routine analysis since they are the most economical, but 
have low mass accuracy. FT-MS is the most accurate mass analyzer however, it is 
also the most costly.  
 There are two approaches to proteomics with mass spectrometry, top-down 
proteomics and bottom-up proteomics. Both have evolved with time and are said to 
be complimentary techniques rather than one being a better approach than the other. 
In top-down proteomics, whole proteins (not subjected to enzymatic digestion) are 
subjected to mass spectrometry analysis (42,43). This approach provides orders of 
magnitude higher specificity at the expense of higher experimental requirements and 
has been successfully applied to proteins of 500 residues to 50 KDa molecular weight, 
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since larger fragments from larger proteins have higher backbone stability and 
fragmentation requires higher amounts of energy. This limit has been greatly 
extended by new methods of ionization such as prefolding dissociation, where 
variable thermal and collisional activation just after electrospray ionization are 
applied (42).  
 Bottom-up proteomics on the other hand, involves working with enzyme 
digested protein samples for mass spectrometry analysis. The proteomic information 
in this approach is built relying on database searches, which in turn rely on good 
protein coverage, which is usually orders of magnitude lower than the top-down 
approach, especially in complex protein mixtures (40,42,43). However, this approach 
is still the more popular and amenable approach due to its higher versatility and 
accessibility.    
1.5 Conclusions and Perspectives on the Study of Protein Nitration 
Proteomics, with the help of Genomics, is a relatively new field that is rapidly 
growing and proving to be essential for the understanding of biological processes 
such as aging, and also understanding disease. Proteins are the dynamic machinery 
that drive all processes in living organisms from conception to death. Identifying 
proteins and their function is a daunting task that proteomics work has undertaken, 
especially due to their existence in different modified states after translation. This is a 
field that is constantly growing and evolving, where new techniques are constantly 
being developed, especially for mass spectrometry and the study of PTMs and their 
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role. Protein Tyr nitration is a major PTM that has been linked to oxidative stress and 
more recently to cell signaling.   
This thesis will present proteomic studies of protein Tyr nitration using 
traditional proteomics methods such as 1D and 2D gel electrophoresis, and antibody 
based techniques such as Western Blot analysis. Here, we will also present the 
application of a novel fluorescent tagging technique specific for hydroxytyrosine 
(DOPA) and nitrotyrosine after the reduction to aminotyrosine, developed by 
collaborations between our group and Dr. Stobaugh’s group. This novel fluorescence 
tag will enhance sensitivity to the analyte and help overcome the problem of low 
protein abundance faced for mass spectrometry analysis. In addition, this new 
fluorescent tagging technique is both qualitative and quantitative, unlike most 
traditional proteomics techniques, which are mainly qualitative. 
From a Scifinder search for Tyr nitration, we can observe that since protein 
Tyr nitration was first discovered in the 1970s, interest in this PTM has increased 
dramatically in the last decade and several proteins have been added to the nitrated 
proteome. Protein Tyr nitration with its link to oxidative stress, has been hypothesized  
to play a role in signal transduction if present at basal levels (9,36), however, 
accumulation of nitrated proteins has been linked to several disease states including 
inflammation (44), cancer (45,46), cardiovascular disease (47-49), atherosclerosis 
(50) and Alzheimer’s disease (51-53). At the same time, the search for biomarkers of 
disease has been and continues to be a major concern both in the medical and the 
pharmaceutical fields (54). 
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All proteins in the nitrated proteome have a potential to be biomarkers of 
disease, however, only a few of them have been studied to functional detail and the 
effects of nitration have been characterized in-vitro. There remains a need for 
studying nitrated proteins to functional detail and more so, to understand whether 
nitration is the cause of the disease or the effect of disease. Such as in the case of 
Alzheimer’s disease, which is characterized by senile plaques in the brain, formed by 
aggregates of proteolytic products of amyloid protein precursor due to protein 
misfolding (55) and the tau protein in neurons (56). To date, cause for these 
aggregates are not very well understood, however, it has been well reported as 
mentioned earlier, that oxidized proteins are more prone to aggregation and, or  
proteolytic degradation (14), therefore, the presence of oxidated proteins in this 
disease may offer some explanation to the cause of protein aggregation that causes 
disease progression.  
There are a lot of pieces to several puzzles and the study and understanding of 
each individual piece is imperative to be able to put the puzzles together and get the 
“big picture”. As important as global proteomics are to increase the number of pieces 
to the puzzle, individual focus by disease and protein will offer the most significant 
information towards the development of novel protein based therapeutics for the 
treatment of disease.  
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2. In-vitro proteomic study of nitrated creatine kinase 
2.1 List of abbreviations used inside the text 
- ROS: Reactive oxygen species 
- RNS: Reactive nitrogen species 
- CK: Creatine Kinase 
- HPLC-ESI-MS/MS: High performance liquid chromatography-electrospray 
ionization tandem mass spectrometry. 
- 3-NY: 3-nitrotyrosine 
- NO: nitrogen monoxide 
- ONOO-: peroxynitrite 
- IAA: Iodoacetic acid 
- ATP: Adenosine triphosphate 
- ADP: Adenosine diphosphate 
- NADH: β-nicotinamide adenosine dinucleotide 
- PK/LDH: pyruvate kinase/lactic dehydrogenase 
- ThioGlo-1™: 10-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-9-methoxy-3-oxo-, 
Methyl Ester 
- 1D SDS-PAGE/1DE: one dimensional sodium dodecyl sulfate polyacrylamide 
gel electrophoresis. 
- BSA: bovine serum albumin 
- DTT: dithiothreitol 
- PVDF polyvinylidene difluoride 
- RP nano LC MS: Reverse phase nano liquid chromatography mass 
spectrometry 
 
2.2 Introduction 
 Creatine kinase (CK) is a 37 kDa protein expressed in high energy demanding 
tissues such as heart, skeletal muscle and brain.  CK plays an important role in energy 
metabolism by effectively catalyzing the formation of ATP by the reversible transfer 
of the phosphoryl group on phosphocreatine to ADP (1,2). Equation 1 is a visual 
representation of this process, where the rate of CK reaction turnover exceeds the rate 
of ATP synthesis by an order of magnitude, allowing for cellular systems to keep up 
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with energy consumption by tissues such as skeletal muscle, especially during 
excersise or other high energy demand activities (2). 
Phorphocreatine + ADP   CK    Creatine + ATP    (Eq. 1) 
Some of the proposed cellular functions for CK range from regulation of 
oxidative phosphorylation, energy buffering, to regulation of chemical potential 
between sites of ATP production and consumption in the form of phosphocreatine (1-
4).  CK (brain isoform) has also been shown to be essential for ATP dependent 
signaling pathways directed to the cytoskeleton in the vascular system by interaction 
with protease-activated receptor-1 (PAR-1), responsible for mediating cellular 
responses to thrombin during blood coagulation, cell proliferation, changes in 
vascular permeability, tumor metastasis and injury to the nervous system (4).   
The active site of CK contains a critical Cys residue, that, if unavailable, may 
significantly decrease enzymatic activity (2,5), thus making CK highly susceptible to 
protein oxidation by reactive oxygen species (ROS) such as superoxide (6,7) and 
reactive nitrogen species (RNS) such as peroxynitrite (ONOO-) (2). Reduced CK  
activity due to posttranslational modifications has been reported in diseases such as 
Alzheimer’s disease, Pick’s disease and Lewy body dementia (3). The presence of 
nitrated CK isoforms has also been reported to accumulate as a function of aging 
(8,9), which led us to the present study. 
In this study, we focused on the oxidative effects of peroxynitrite on CK. We 
treated CK with different levels of peroxynitrite and found that enzymatic activity 
decreases significantly with increasing levels of oxidant. In these in-vitro studies, we 
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found that the only oxidized Cys residue out of four cysteins was Cys283, the critical 
Cys in CK’s active site (2,5). This Cys residue is strategically positioned in the 
catalytic site of CK and is thought to directly participate in catalysis of energy 
metabolism. Therefore, any change in this Cys residue may trigger a change in the 
geometry and steric access of CK’s active site, affecting its activity (10). Interestingly 
but not so surprisingly, Tyr82 was the main nitration site in-vitro, however, the main 
Tyr nitration sites found in-vivo were Tyr14 and Tyr20 (11). This experimental result 
illustrates that in-vitro studies do not always mimic processes that occur in-vivo.  
2.3 Experimental 
Materials 
 Creatine Kinase (CK), dithiotreitol (DTT), N-acetyl-Cys, Coomassie brilliant 
blue, iodoacetic acid (IAA), adenosine triphosphate (ATP), β-nicotinamide adenosine 
dinucleotide (NADH), phosphoenol pyruvate (PEP), pyruvate kinase/lactic 
dehydrogenase (PK/LDH), glutathione (reduced form) and creatine were purchased 
from Sigma-Aldrich  Chemical Company (St.Louis, MO), and was nitrated with 
peroxynitrite (ONOO-) synthesized in the laboratory according to Beckman et. al. 
(12). Tris/HCl, MgCl2 sodium phosphate diabasic (Na2HPO4), guanidine-HCl and 
sequencing grade trypsin
 
were purchased from Fisher Scientific (Pittsburg, PA). De-
ionized distilled water was filtered by a Labconco purification system (Kansas City, 
MO). Pre-cast 4-20% SDS-PAGE gels and Tris-glycine SDS 2X sample buffer were 
purchased from Invitrogen (Carlsbad, CA) and the X-ray films were purchased from 
Kodak (Rochester, NY). The anti-3-nitrotyrosine (anti-3-NY) monoclonal antibody, 
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clone 1A6, was purchased from Upstate, Inc. (Charlottesville, VA), and the anti-
mouse IgG Fc-peroxide-conjugated antibody was purchased from Pierce 
Biotechnology (Rockford, IL). ECL-Plus reagents were purchased from GE 
Healthcare (Piscataway, NJ). Powdered milk was purchased from Nestlé-Carnation 
(Glendale, CA). Polyvinylidine fluoride (PVDF) membranes were purchased from 
Millipore (Billerica, MA). 10-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-9-methoxy-3-
oxo-, Methyl Ester (ThioGlo-1™) was obtained from Covalent Associate Inc. 
(Woburn, MA). 
In-vitro protein nitration 
 A 1 mg/ml solution of CK was prepared in 50 mM Tris/HCl-5mM MgCl2 
buffer at pH 8. The protein solution was distributed among 5 Eppendorf™ tubes, each 
aliquot containing 200 µl. The concentration of peroxynitrite in the stock solution was 
measured to be 88 mM by UVspectroscopy. Each aliquot was treated with different 
levels of peroxynitrite, 1mM, 0.5 mM, 0.2 mM, 0.1 mM and 0 mM in solution. The 
peroxynitrite was added to the inner wall of the tube right above the protein solution 
and vortexed for 5 seconds.  
Gel electrophoresis 
 50 µl of each sample were diluted with 2X sample buffer for a total volume of 
100 µl. These samples were distributed among 2 pre-cast SDS-PAGE gels, which 
were run simultaneously. The first gel was used for protein Coomassie blue staining 
(Figure 2.1) and the second gel was used for Western blot analysis.  
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Figure 2.1 SDS-PAGE analysis for in-vitro nitrated creatine kinase (CK). 
Total protein load by coomassie blue staining, ~12.5 µg of protein per lane. 0, 100, 200 and 500 
represent the micromolar concentrations of ONOO- in each CK sample.  
Western Blot  
 The second gel was taken from its cast and the proteins were transferred onto 
a PVDF membrane using a Hoeffer transfer apparatus (Hoeffer Scientific Instruments, 
San Francisco, CA). The transfer was done at 100 V for 2 hrs. The membrane was 
briefly washed in TBST buffer prepared by adjusting a solution of 150mM NaCl and 
20mM Tris to a pH of 7.4, prior to the addition of 0.05% (v/v) Tween 20. The 
membrane was blocked overnight in a 5 % milk solution prepared also in TBST at 
3oC. The membrane was washed 3 times, 15 min each with TBST and then it was 
incubated with the primary ant-nitrotyrosine antibody for 1 hr in a ratio of 1:4000 also 
in TBST. The previous wash step with TBST for the membrane was repeated one 
more time. The membrane was then incubated with the secondary antibody at a ratio 
of 1:10000 in TBST for another hour. The wash step was repeated one more time and 
finally, the membrane was placed on a transparent film flat surface removing excess 
buffer. The ECL Plus reagent was applied according to manufacturer’s directions and 
0     100     200     500 
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was incubated for 5 min. The membrane was covered with another transparent film 
and was placed inside a developing cassette. In the dark room, an x-ray film exposed 
to the membrane by placing it directly on top of the membrane inside the cassette. 
The x-ray film was then developed according to film developing procedures. Figure 
2.2 shows the Western blot for CK treated with different concentrations of ONOO-.    
 
 
 
 
 
 
Figure 2.2 Western blot analysis of ONOO- treated CK with anti-3NY antibody 
Visual display of the extent of Tyr nitration by the different levels of ONOO- applied to the 
samples.The numbers 0, 100, 200, 500 and 1000 represent the micromolar concentration of ONNO- in 
each sample. 
 
Protein Activity Assay 
The protocol for performing the activity assay for CK was obtained from 
Worthington Biochemical Corporation (WBC) at http://www.worthington-
biochem.com/CRK/assay.html. Creatine kinase activity in this assay was determined 
by a coupled enzyme with pyruvate kinase (PK) and lactic dehydrogenase (LDH). 
Essentially, one activity unit in this assay is defined as the conversion of 1 µM of 
creatine to creatine phosphate in one minute at room temperature and at pH 8.9.  
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Cys Quantitation with ThioGlo-1™ 
 ThioGlo-1™ (Figure 2.3) is a reagent that rapidly reacts with free thiols to 
yield fluorescent adducts.  First, a 18.75 mM Na2HPO4 buffer solution was prepared. 
Then, 19.5 µl of each 1 mg/ml protein sample was taken and diluted with 630.5 µl of 
phosphate buffer for a total of 650 µl. To each of these samples, guanidine-HCl was 
added for denaturation at a final concentration of 6 M. A 50 mM ThioGlo™ solution 
was prepared in dimethylformamaide (DMF). 200 µl aliquots of each protein solution 
treated with different amounts of ONOO-,  were transferred to individual wells in a 96 
well plate and 3 µl of ThioGlo-1™ were added to each well for a final concentration 
of 15 µM ThioGlo-1™ (this was step was done in 3 replicates). The standards were 
made with N-Acetyl-Cys. The blanks used were first 18.75 mM Na2HPO4, second 
18.75 mM Na2HPO4 plus guanidine-HCl and third 18.75 mM Na2HPO4 plus 
guanidine-HCl plus ThioGlo-1™. The free Cys residues in the samples were 
determined from the milli fluorescence units extrapolated from the N-acetyl-Cys 
standard curve. (Figure 2.4) 
 
Figure 2.3 ThioGlo-1™ reagent 
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A) 
 
 
 
 
 
 
 
 
B)  
 
 
 
 
 
 
 
 
Figure 2.4 ThioGlo-1™ experiment results.  
(A) Standard curve obtained from serial dilution of the standard N-acetyl-Cys taken from 10 µM to 1 
µM. This standard curve was used to calculate micromoles of free Cys residues in our nitrated CK 
samples. Loss of free Cys residues due to increased oxidation by ONOO- was demonstrated by this 
experiment. 
Standard curve N-acetyl-Cys
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In-gel trypsin digestion 
 Protein bands from the Coomassie-stained gel were cut out and were 
subjected to an in-gel trypsin digest procedure. The gel bands were first crushed into 
smaller pieces and washed with 400 µl of a 200mM NH4HCO3/MeCN (50:50) 
solution by incubating them at 40oC for 45 minutes.  The previous wash step was 
repeated twice by switching the wash solution until all the blue color was washed off 
the gel pieces. Then, the final wash solution was removed and replaced with 200 µl of 
200 mM NH4HCO3 buffer and 20 µl of 200 mM DTT for reduction of disulfide bonds. 
The samples were incubated at 55.9oC for exactly 30 min at this step. Then, 20 µl of 
500 mM IAA were added to each tube and incubated at room temperature for another 
30 min for alkylation of free thiols. Following this step, all the solution was removed 
and 200 µl of wash solution were added to the tubes and were incubated for 1 hour. 
Then, the wash solution was removed and 200 µl of pure MeCN were added to 
dehydrate the gel pieces. Finally, 2 µg of trypsin were added to each sample in ~ 50 
to 60 µl of 50 mM NH4HCO3 and incubated at 37oC overnight. The digested protein 
samples were saved for mass spectrometry analysis.  
Mass spectrometry analysis 
Solution digests were analyzed by nanoHPLC-ESI-MS/MS on either a 
Thermoelectron LCQ Duo or a Thermoelectron Classic ion trap mass spectrometer, 
both equipped with a nanoelectrospray source (Thermoelectron, Waltham, MA). 
Separation of the tryptic peptides was achieved prior to MS/MS analysis on an in-
house packed C18 Biobasic stationary phase (Thermoelectron, Waltham, MA) 
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nanoflow column (300 A, 10 cm x 75 µm, 15 µm tip size) (New Objective, Woburn, 
MA). The following chromatographic conditions were applied: mobile phase A: 0.1% 
formic acid in water, mobile phase B: 0.1% formic acid in acetonitrile. The flow rate 
was adjusted to 0.5 µl/min with the chromatographic flow delivered by either an 
Ultraplus 2 pump after 1:20 split (Microtech Inc, CA) or directly by an Xtreme 
simple nanoflow pump (Microtech Inc., CA). The gradient profile applied to the 
separation of peptides from in-gel digests included the following steps for mobile 
phase B: 0 to 5 minutes held at 10%, then linearly increased to 60% between 5 and 45 
minutes; held at 60% until 50 minutes before being readjusted to the initial 
equilibration conditions for the next run (15 minutes). The following instrument 
conditions were used for the mass spectrometer: number of microscans = 3, length of 
microscans = 200 ms, capillary temperature = 160 °C, spray voltage = 1.9 kV, 
capillary voltage = 35, tube lens offset = -14V. The tuning for both mass 
spectrometers was performed using a static nanospray setup with a 5 µM solution of 
angiotensin 1 (MW = 1296.5 Da) infused by a picotip emitter (New Objective) (13). 
The data acquisition was performed in a data-dependent manner such that an MS scan 
was followed by 3 or 4 MS/MS scans of the 3 or 4 most intense peaks with the 
normalized collision energy for MS/MS set at 35% and the isolation width of 2.0 m/z. 
A minimal signal threshold of 2 x 106 was set for acquiring the MS/MS data. 
Additionally, the dynamic exclusion option was enabled with the following 
parameters: repeat count = 3, repeat duration = 5 ms, exclusion list size = 25, 
exclusion mass width = 3. 
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Protein Identification 
The MS/MS data were subjected to a protein database search using the 
Bioworks 3.1 software (Thermoelectron). The most recently updated non-redundant 
NCBI protein database was used for the searches when downloaded from 
ftp.ncbi.nlm.nih.gove/blast/db (13) with the following amino acid modifications 
included in the search options: oxidation of Met (+16 amu; amu = atomic mass units), 
alkylation of cysteine (+57 amu) and nitration of tyrosine (+45 amu). The protein was 
identified with a 77 % sequence coverage, where only Tyr 82 was found to be nitrated 
in these in-vitro studies.  
2.4 Results  
Previous in-vivo studies in cardiac muscle indicated that CK is one of the 
main targets for protein Tyr nitration in the heart (9). CK was also found to be 
nitrated in skeletal muscle at the same time these experiments were being conducted 
(11). The goal of this project was to study in better detail, a protein from the previous 
list of proteins found to be nitrated in-vivo. CK was of interest because of its 
importance in energy metabolism.  
Commercially available CK was treated with various concentrations of ONOO-. As 
expected, increasing concentrations of ONOO- resulted in increased protein oxidation 
levels. This was observed both by Western Blot analysis with a monoclonal anti-3-
NY antibody, which showed Tyr nitration, and ThioGlo-1 analysis, which showed 
Cys oxidation. We also tested the activity of oxidized CK by ONOO- and found that 
results were in agreement with our hypothesis that increased levels of protein 
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oxidation result in increased loss of activity. There was a linear correlation between 
the oxidant concentration in the samples to loss of CK activity in the samples (Figure 
2.5). 
 
Figure 2.5 Measurement of CK activity 
CK activity is defined as the conversion of 1 µM of creatine to creatine phosphate in 1 min at 25oC 
with the consumption of NADH. Here, we measured NADH consumption at 340 nm in a 20 minute 
frame. Here, there is a clear indication that activity (NADH consumption) decreases with increased 
levels of nitration. 
 
 Through mass spectrometry analysis, we identified CK with a sequence 
coverage of 77% (Figure 2.6), where nine Tyr out of ten residues were accounted. 
Only Tyr82 was found to be nitrated in-vitro as opposed to Tyr14 and Tyr20 found to be 
nitrated in-vivo studies in skeletal muscle proteins (11). Four Cys residues out of four 
Cys residues were accounted for, Cys74, Cys146, Cys254 and Cys283. However, when 
we searched for Cys + 16 for sulfenic acid (Cys-SOH), Cys + 32 for sulfinic acid 
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(Cys-SO2H) and Cys + 48 for sulfonic acid (Cys-SO3H) in our mass spectrometry 
data, we only found Cys283 oxidized to sulfonic acid, although, loss of Cys residues 
was found to increase to near complete loss by ThioGlo-1™ with increasing levels of 
ONOO-. This can be explained by the fact that mass spectrometry analysis was 
conducted under reducing conditions and therefore, cannot account for Cys oxidation 
due to disulfide bridge formation, or reduction of Cys sulfenic and Cys sulfinic acid 
to Cys under reducing conditions (14,15). 
 
MPFGNTHNKF KLNYKPEEEY PDLSKHNNHM AKVLTLELYK KLRDKETPSG FTVDDVIQTG 
VDNPGHPFIM TVGCVAGDEE SYEVFKELFD PIISDRHGGY KPTDKHKTDL NHENLKGGDD 
LDPNYVLSSR VRTGRSIKGY TLPPHCSRGE RRAVEKLSVE ALNSLTGEFK GKYYPLKSMT 
EKEQQQLIDD HFLFDKPVSP LLLASGMARD WPDARGIWHN DNKSFLVWVN EEDHLRVISM 
EKGGNMKEVF RRFCVGLQKI EEIFKKAGHP FMWNQHLGYV LTCPSNLGTG LRGGVHVKLA 
HLSKHPKFEE ILTRLRLQKR GTGGVDTAAV GSVFDVSNAD RLGSSEVEQV QLVVDGVKLM 
VEMEKKLEKG QSIDDMIPAQ KL 
 
Figure 2.6 Creatine Kinase protein amino acid sequence.  
The sequences covered by mass spectrometry analysis are highlighted in red. The oxidized amino acids 
Tyr82 and Cys283 are highlighted in blue. 
 
2.5 Discussion/Conclusions 
 In-vivo, skeletal muscle cytosolic CK was found to undergo nitration of both 
Tyr14 and Tyr20 but, Tyr residues at positions 39, 82, 125, 140, 173, 174, and 279 
were not affected. In contrast, in-vitro exposure of CK to peroxynitrite was found to 
nitrate exclusively Tyr82. This illustrates the continuous dilemma where in-vitro 
studies may not always be a reflection of what actually occurs in-vivo. These 
significant differences in nitration patterns between in-vivo and in-vitro samples were 
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not caused by any analytical discrimination against specific Tyr- and/or 3-NY-
containing peptides because in both studies, we got good coverage of remaining 
unmodified Tyr residues. The distinct patterns of nitration may have been caused by 
one or a combination of the following factors. (i) Specific nitrated isoforms of CK 
may be degraded in-vivo through the proteasome, known for its ability to degrade 
proteins exposed to peroxynitrite (16).  Specific nitrating agents may nitrate proteins 
predominantly at specific locations, while generating negligible amounts of 3-NY at 
other positions. The predominant nitrated species may be susceptible to proteasomal 
degradation, while the protein isoforms containing the non-specific nitration sites 
may be subject to accumulation with time and therefore detected by proteomic 
methods. (ii) In-vitro reaction conditions were not physiological. The buffer used was 
50 mM Tris/HCl-5 mM MgCl2 at pH 8. These non-physiological conditions may 
cause some conformational changes in CK, making other regions more susceptible to 
oxidation, compared with in vivo conditions. (iii) There are other nitrating species in-
vivo, in addition to peroxynitrite. Some evidence for protein nitration through  
has been provided (17), and to date it is not known to which extent peroxynitrite, 
peroxynitrite -CO2 adduct, , and/or potentially other hitherto unknown nitrating 
species, are responsible for protein nitration in-vivo. (iv)  In-vivo, CK may exist in 
complexes with other proteins or small molecules such as phosphocreatine and ATP. 
These complexes may be largely responsible for the chemical selectivity for Tyr 
nitration. Such phenomena were demonstrated in previous experiments with 
calmodulin (CaM), where CaM complexation with calmodulin-binding peptides and 
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proteins, melittin and nitric oxide synthase 2, have changed its susceptibility to 
oxidation by peroxynitrite (18). In addition, Mihm et al.(19) have recognized a 
protective effect of phosphocreatine and ATP on CK toward oxidation by 
peroxynitrite.  
To further illustrate how complexation can affect susceptibility to nitration, an 
earlier study focused on mitochondrial CK oxidation by peroxynitrite, showed 
evidence of Trp264 and Trp268 nitration but no Tyr nitration by MALDI-TOF mass 
spectrometry (20). These findings are different from our results with cytosolic CK, 
that displayed Tyr nitration both in-vivo and in-vitro. An important difference found 
between the cytosolic and mitochondrial isoforms of CK is their aggregation state. 
Cytosolic CK exists exclusively in dimers, whereas mitochondrial CK exists in 
octamers. The differential sensitivity of the individual isoforms toward the nitration of 
Tyr vs. Trp, and the differences in the cytosolic isoforms toward nitration in-vivo and 
in-vitro, highlight the importance of protein structure and environment on product 
formation during oxidative stress. One important aspect to note however, is that both 
CK isoforms (mitochondrial and cytosolic), suffer inactivation in part due to 
oxidation of a critical Cys residue, Cys278 (mitochondria) (20) and Cys283 (cytosol) (5).  
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3. In-vivo proteomic study of nitrated proteins in cardiac tissue as a function of 
aging 
3.1 List of abbreviations used inside the text 
- ROS: Reactive oxygen species 
- RNS: Reactive nitrogen species 
- BN-F1: Fisher 344 Brown Norway F1 rats 
- IEF: Isoelectric focusing 
- HPLC-ESI-MS/MS: High performance liquid chromatography-electrospray 
ionization tandem mass spectrometry. 
- 3-NY: 3-nitrotyrosine 
- NO: nitrogen monoxide 
- ONOO-: peroxynitrite 
- Mn-SOD: manganese superoxide dismutase 
- GR: glutathione reductase 
- SR: sarcoplasmic reticulum 
- RyR: ryanodine receptor 
- SERCA: sarco/endoplasmic reticulum Ca-ATPase 
- 2DE: two-dimensional gel electrophoresis 
- 1D SDS-PAGE/1DE: one dimensional sodium dodecyl sulfate polyacrylamide 
gel electrophoresis. 
- N-RAP: nebulin-related anchoring protein 
- BSA: bovine serum albumin 
- DTT: dithiothreitol 
- CHAPS: 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate  
- PVDF polyvinylidene difluoride 
- TBST: tris-buffered saline with tween 
- RP nano LC MS: Reverse phase nano liquid chromatography mass 
spectrometry 
 
3.1 Introduction 
Protein nitration may affect protein structure, function, and turnover. An 
illustrative example is the mitochondrial manganese superoxide dismutase (Mn-SOD), 
which catalyzes the disproportionation of superoxide to O2 and H2O2. Mn-SOD was 
found to undergo almost complete inhibition when nitrated at Tyr34 (1-3). The crystal 
structures of native Mn-SOD and nitrated Mn-SOD were found to be closely 
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superimposable; however, the nitration of Tyr34 disrupts the H-bonding network at the 
active site, which may be the reason for protein inactivation (1). A crystal structure 
was also obtained for nitrated glutathione reductase (GR) (4). Here, the nitration of 
two Tyr residues, Tyr106 and Tyr114, was found to be responsible for protein 
inactivation. Comparison of the crystal structures of both native and nitrated GR 
shows that specifically the hydroxy group of 3-NY114 appears to be rotated by ~60o 
due to the creation of a local negative charge that changes the electrostatics of the 
active site (4).  
There is a significant age-dependent accumulation of 3-NY on proteins in 
cardiac (5) and skeletal muscle (6). Cardiac proteins are highly susceptible to 
nitration due to the periodic formation of NO and superoxide,
 
mediating myocardial 
contractility (7-9). NO can regulate cardiac function through the S-nitrosation of 
effector molecules such as Ca2+ ion channels, in particular the plasmalemmal L-type 
calcium channel and the sarcoplasmic reticulum (SR) ryanodine receptor (RyR) 
(9,10). Through intermediary formation of peroxynitrite, NO also indirectly regulates 
the activity of another Ca2+-transporting enzyme, the sarco/endoplasmic reticulum 
Ca-ATPase (SERCA) (11).  
Earlier, we had communicated two-dimensional gel electrophoresis (2DE) 
experiments targeted at the identification of cardiac proteins susceptible to nitration, 
and a list of 48 putatively nitrated proteins was assembled (5). However, due to the 
known limitations of the 2DE method (limited sample load, discrimination against 
membrane proteins and proteins of very low and very high molecular weight and pI), 
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only one nitration site was actually located by MS/MS (for the electron transfer 
flavoprotein). In order to overcome the limitations of traditional 2DE, we have now 
applied a combination of solution isoelectric focusing, 1D SDS-PAGE and reversed-
phase chromatography coupled to nanoelectrospray ionization-MS/MS analysis to 
identify cardiac proteins subject to age-dependent nitration. We will demonstrate here 
that biological aging results in the accumulation of 3-NY on distinct protein 
sequences, including a zinc-finger and nebulin-related anchoring protein (N-RAP). Of 
particular interest is also the accumulation of 3-NY on Tyr 491 of neurofibromin, 
observed for cardiac tissue from both young and old rats. 
3.2 Experimental 
Materials 
The research protocol was approved by the University of Kansas Animal Care 
Facility; we used 17 Fisher 344/BN F1 rats (ten 34 months old and seven 5 months 
old) These rats were housed in a 12 hour light/dark cycle with food and water 
provided ad libitum. The animals were decapitated, the hearts were removed and 
frozen immediately at –80oC and stored until needed. 
For 1D gel electrophoresis experiments (1DE), Tris-glycine sample and 
running buffers and pre-cast 4-20% gels were obtained from Invitrogen (Carlsbad, 
CA). For Western blotting experiments, TBST buffer was prepared by adjusting a 
solution of 150mM NaCl and 20mM Tris, pH 7.4, prior to the addition of 0.05% (v/v) 
Tween 20. The anti-3-nitrotyrosine (anti-3-NY) monoclonal antibody, clone 1A6, was 
purchased from Upstate, Inc. (Charlottesville, VA), and the anti-mouse IgG Fc-
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peroxide-conjugated antibody from Pierce Biotechnology (Rockford, IL). X-ray film 
was purchased from MIDSCI (St. Louis, MO).  Powdered milk was purchased from 
Nestlé-Carnation (Glendale, CA). Polyvinylidine fluoride (PVDF) membranes were 
purchased from Millipore (Billerica, MA). ECL-Plus reagents were purchased from 
GE Healthcare (Piscataway, NJ). Sequencing grade trypsin
 
was purchased from 
Fisher Scientific (Pittsburg, PA). Protein concentration was quantified with the 
reducing-agent compatible BCA Protein Assay Kit, purchased from Pierce 
Biotechnology (Rockford, IL). Complete EDTA-free protease inhibitor cocktail 
tablets were purchased from Roche Applied Science (Indianapolis, IN). Bovine serum 
albumin (BSA), sodium dodecyl sulfate (SDS), dithiothreitol (DTT) and 
iodoacetamide were obtained from Sigma Chemicals (St. Louis, MO), and the 3/10 
ampholite solution for solution isoelectric focusing was provided by Bio-Rad, Inc. 
(Hercules, CA).  
Sample Preparation 
For each analysis proteins were pooled from either 2 or 3 hearts from 34 month or 5 
month old rats, respectively. The hearts were cut into small pieces, and the tissue 
rinsed twice in tissue wash buffer (50mM Tris, 150mM NaCl, 10µg/ml protease 
inhibitor cocktail mixture) to remove as much hemoglobin as possible. Subsequently, 
the tissue was homogenized in 25 ml of lysis solution (6M urea, 2% CHAPS, 10mM 
Tris, 0.5mM PMSF, 10µg/ml protease inhibitor cocktail mixture, 20 mM DTT, pH 
7.5) using an ultra-turrax T8 homogenizer (Fisher, Pittsburg, PA). Finally, the 
homogenate was centrifuged at 5,500 g at 4oC for 30 minutes. The supernatant was 
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collected for analysis, taking care that the pellet was not disturbed during sampling of 
the supernatant. 
1DE and Western Blot Analysis  
Either total cardiac protein or proteins obtained in the individual fractions 
after solution isoelectric focusing were precipitated (see below). The precipitated 
proteins were redissolved in 100µl of 50mM NH4HCO3 buffer, pH 7.4, containing 
0.02% SDS. Protein concentrations were measured with the BCA Protein Assay Kit 
according to the manufacturer’s protocol. Protein samples were mixed with equal 
volumes of sample buffer, boiled for 5 minutes in the presence of 20mM DTT, and 
cooled for another 5 minutes prior to separation on precast 4-20% gels for 75 minutes 
at 5oC, at a constant voltage of 200V.  
 For Western blot analysis, proteins were transferred from the gels onto 
0.45µm polyvinylidene difluoride (PVDF) membranes at a constant voltage of 100V 
for 2hrs. The PVDF membranes were blocked with 5% (w/v) milk-TBST buffer for 
1hr at room temperature. The membranes were incubated overnight at 3oC with the 
primary anti-3-NY antibody (1:4000 dilution in 5% (w/v) milk-TBST buffer). 
Subsequently, the membranes were washed with 5%(w/v) milk-TBST buffer twice 
for 15 minutes prior to incubation with the anti-mouse IgG Fc-peroxide-conjugated 
secondary antibody (1:10,000 dilution in 5% (w/v) milk-TBST buffer) for 1hr at 
room temperature. The membranes were thoroughly washed with 2 short washes of 
5% (w/v) milk-TBST buffer, followed by three 30 minute washes with TBST buffer 
alone. The immunoblots were visualized by chemiluminescence using the ECL kit 
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(GE Healthcare, Piscataway, NJ) according to the manufacturer’s protocol. The 
images were captured on a Kodak X-ray film using a Kodak developer/fixer kit.  
 The densitometry analysis for both the SDS-PAGE and Western blot was 
achieved with the Image Quant software (Amersham Biosciences; Pittsburgh, PA). 
Solution Phase Isoelectric Focusing (IEF) 
 To the supernatant of the homogenized and centrifuged cardiac tissue, 500µl 
of 3/10 carrier ampholite solution were added. The solution was slowly mixed for a 
few minutes and was loaded into a Bio-Rad Rotofor mini-focusing chamber (Figure 
3.2) according to the manufacturer’s protocol. Briefly, the anode membrane was 
conditioned in 0.1 M H3PO4 and the cathode membrane was conditioned in 0.1 M 
NaOH overnight. The apparatus was assembled according to the guidelines provided 
by the manufacturer. A total of 18 ml containing between 10-15mg/ml protein sample 
was applied to the Rotofor focusing chamber and fractionated at a constant power 
setting (12 W) at 4oC. The voltage stabilized at 524 V after about 30-40 minutes and 
increased to 2400 V  after 3 hours when protein fractionation was stopped. The 
samples were then collected into 20 test tubes, each representing a discrete pH region. 
These samples were processed further immediately. 
Reduction, Alkylation and Protein Precipitation 
50µl of each Rotofor fraction were adjusted to a volume of 100µl with 50mM 
NH4HCO3 buffer, pH 7.4. The fractions were treated with 2mM DTT for 30 min at 
37oC to reduce disulfide bonds, followed by alkylation with 5mM iodoacetamide for 
30 min at room temperature. Subsequently, proteins were precipitated overnight at -
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20oC by addition of 1 ml of pure ethanol to the reaction mixtures. The precipitated 
proteins were collected by centrifugation at 13,000g for 5 minutes. The supernatants 
were discarded and the solid protein pellets were saved for further processing.  
Solution Digestion 
 Precipitated proteins were collected and re-dissolved in 100-200µl of 50mM 
NH4HCO3, pH7.4. To each sample, 2µg of trypsin were added and digestion was 
carried out overnight at 37oC. The digests were then analyzed by nanoHPLC-
electrospray ionization (NSI)-tandem mass spectrometry (MS/MS). 
Nanoelectrospray ionization-tandem mass spectrometry (NSI-MS/MS) analysis 
Solution digests were analyzed by nanoHPLC-ESI-MS/MS on either a 
Thermoelectron LCQ Duo or a Thermoelectron Classic ion trap mass spectrometer, 
both equipped with a nanoelectrospray source (Thermoelectron). Separation of the 
tryptic peptides was achieved prior to MS/MS analysis on an in-house packed C18 
Biobasic stationary phase (Thermoelectron, CA) nanoflow column (300 A, 10 cm x 
75 µm, 15 µm tip size) (New Objective, Woburn, MA). The following 
chromatographic conditions were applied: mobile phase A: 0.1% formic acid in water, 
mobile phase B: 0.1% formic acid in acetonitrile. The flow rate was adjusted to 0.5 
µl/min with the chromatographic flow delivered by either an Ultraplus 2 pump (after 
1:20 split; Microtech Inc, CA) or directly by an Xtreme simple nanoflow pump 
(Microtech Inc., CA). The gradient profile applied to the separation of peptides from 
in-gel digests included the following steps for mobile phase B: 0 to 5 minutes held at 
15%, then linearly increased to 70% between 5 and 35 minutes; held at 70% until 40 
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minutes before being readjusted to the initial equilibration conditions. For peptides 
recovered from solution digests, the increase in composition of B from 15 to 70% was 
instead accomplished over a much slower time period of 95 minutes such that the 
total run time was extended to 2 hours for each sample. The following instrument 
conditions were used for the mass spectrometer: number of microscans = 3, length of 
microscans = 200 ms, capillary temperature = 160 °C, spray voltage = 41 V, tube lens 
offset = -10V. The tuning for both mass spectrometers was performed using a static 
nanospray setup with a 5 µM solution of angiotensin 1 (MW = 1296.5 Da) infused by 
a picotip emitter. The data acquisition was performed in a data-dependent manner 
such that an MS scan was followed by 3 or 4 MS/MS scans of the 3 or 4 most intense 
peaks with the normalized collision energy for MS/MS set at 35% and the isolation 
width of 2.0 m/z. A minimal signal threshold of 2 x 106 was set for acquiring the 
MS/MS data. Additionally, the dynamic exclusion option was enabled with the 
following parameters: repeat count = 3, repeat duration = 5 ms, exclusion list size = 
25, exclusion mass width = 3. 
Protein Identification 
The MS/MS data were subjected to a protein database search using the 
Bioworks 3.1 software (Thermoelectron). The most recently updated non-redundant 
NCBI protein database was used for the searches when downloaded from 
ftp.ncbi.nlm.nih.gove/blast/db with the following amino acid modifications included 
in the search options: oxidation of Met (+16 amu; amu = atomic mass units), 
alkylation of cysteine (+57 amu) and nitration of tyrosine (+45 amu). Additionally, 
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the observed MS/MS data of proteins were manually examined for the presence of 3-
NY-containing peptides. 
Database Search and data interpretation 
The following criteria were set for positive identification of nitrated peptides: 
1) For singly, doubly, and triply charged peptides, we set Xcorr values (the cross-
correlation value from the search for well matched peptides (12) ) of ≥ 1.0, ≥ 2.0, 
2.5, respectively. 
2) The major peaks in the MS/MS spectra needed to be unambiguously assigned 
to peptide fragments of the nitrated protein. 
3) Positive identification of nitrated proteins is contingent upon identification of 
at least one non-nitrated, native peptide from the respective protein besides the 3-
NY containing peptide. 
Once a list of proteins of interest was compiled, Protein Prospector v 4.0.6 MS-
product (http://prospector.ucsf.edu/ucsfhtml4.0/msprod.htm) was used to analyze the 
data manually. During this procedure, we were able to find peaks corresponding to 
internal fragments, and neutral losses of H2O, NH3 and CO. The spectra with all 
major peaks labeled unambiguously identified the nitrated peptides found during the 
analysis.  
3.3 Results  
 1D SDS-PAGE and Western blot analysis (Figure 3.1) confirmed our earlier 
data (5) that nitrated proteins are present in cardiac tissue, and that their abundance 
increases with age. Based on densitometry analysis, ca. 1.5 to 2 fold increase in 
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protein nitration, depending on the animal set, when 34 months old animals were 
compared to 5 months old animals. The data were normalized to account for some 
differences of protein load between the individual lanes. 
 
(A)                                                                  (B) 
 
Figure 3.1 SDS-PAGE and Western blot analysis of whole heart homogenates from 4 different 
animals. 
(A) total protein (by coomassie blue staining) and (B) the levels of 3-NY (using a anti-3-NY antibody). 
Four animals are represented in this figure, two 5 months old rat hearts (Y1, Y2) and two 34 months 
old rat hearts (O1 ,O2). The protein amounts in each lane were determined by densitometry analysis 
and normalized to conclude that there is a 1.5 to 2.0 fold increase in nitration with aging.  
 
In the present work we applied solution IEF to pre-fractionate proteins prior to 
tryptic digestion and analysis of the resulting peptides with nano-HPLC-NSI-MS/MS 
(Figure 3.2). Solution IEF permits higher protein loads compared to gel IEF, the first 
step in a traditional 2DE, enhancing the likelihood for positive identification of 
25.0     24.1   30.4     28.2              12.5     11.0   23.4   14.5  (µg)(µg) 12.5 11.0 23. 4
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nitrated peptides. The initial protein amount applied to solution IEF was calculated 
based on the total amount of protein present in the homogenate.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Solution phase isoelectric focusing scheme. 
Protein resolution according to pI, in cardiac tissue homogenate of both young (5 months old) and old 
(34 months old) rats.  
 
After IEF, aliquots from each of the collected fractions were used for pH 
measurements, and others were applied to 1DE analysis and recovered proteins were 
quantified by densitometry. Every fraction contained a different protein load, varying 
from ~1.4 mg/ml to ~56 mg/ml. The pH of the recovered fractions changed gradually 
from 3 to 10, where the pH changed by 0.5 or 1 unit every two or three fractions, as 
was expected based on the separation conditions used. The pIs of the identified 
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nitrated proteins did not necessarily match the pH of the rotofor fraction from which 
they were recovered. The latter may have various reasons such as additional post-
translational modifications, or in vivo proteolysis yielding protein fragments rather 
than intact protein. Our 2 hour nanoHPLC separation prior to MS/MS analysis 
(Materials and Methods section) routinely yielded about 2500 identified peptides per 
fraction. Table 1 summarizes our MS/MS analysis of cardiac proteins from 5 and 34 
months old rats. A total of 10 nitrated proteins were identified. Two of these, myosin 
heavy chain polypeptide 7 and neurofibromin were observed in cardiac homogenates 
from both ages. For each protein on the list, we were able to detect at least one 3-NY-
containing peptide along with a number of non-nitrated peptides. Hence, 
identification of some native peptides in addition to the nitrated peptides confirmed 
the presence of the identified protein in the respective IEF fraction, improving the 
reliability of the protein identification. 
 We note that the molecular weights of the nitrated proteins identified by MS/MS 
analysis (Table 1), and those of the immunoresponsive bands in the Western blot 
analysis (Figure 1B) do not correlate. There are several possible reasons for this: (i) in 
vivo proteolysis of nitrated proteins (see also above); (ii) not all nitrated proteins 
detected by MS/MS will display immunoresponsive spots on the Western blot due to 
the fact that the anti-3-NY antibody can discriminate against selected nitrated proteins 
(13); (iii) not all immunoresponsive proteins on the Western blot will contain 
sufficient yields of 3-NY for the positive MS/MS identification of nitrated peptides. It 
is also important to note that the table of identified proteins by MS/MS in this paper is 
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very different from the list that was generated by traditional 2DE analysis in our 
previous study (5). The only protein that was found in common in both studies was 
Tropomyosin 1, α chain. This may again be due to the inherent differences in the 
methods that were applied to each study. 
MS/MS spectra are shown for all of the proteins identified in the samples 
from 34 months old rat cardiac tissue. These include the nitrated peptide Glu5968-
Arg5978 (Figure 3.3) from nebulin-related anchoring protein (N-RAP) isoform C 
(GenInfo accession number 109468170), nitrated at Tyr5969, the nitrated peptide  
 
Figure 3.3 Representative MS/MS spectrum of nebulin-related anchoring protein (N-RAP) 
Displayed is the MS/MS of the nitrated peptide sequence Glu5968-Arg5978 detected for nebulin-
related anchoring protein (N-RAP), in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we 
have highlighted the y-ions covered in the series, y2-y10. 
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a
 Gen Info accession number.  
Table 3.1 List of nitrated proteins identified by solution IEF and NSI-LC-MS/MS in cardiac tissue studies 
The study was done on cardiac tissue of 5 months old and 34 months old Fisher 344 BN-F1 rats. The specific nitrated sequences for each protein 
are shown here. 
 
 
 
Sample Protein GI no. a Molecular 
mass 
(KDa) 
% Coverage No. of 
identified 
peptides 
Nitrated peptide Sequence Cellular location and function 
5 months old 
rat cardiac 
tissue 
Myosin heavy chain 
polypeptide 7 
8393807 222.9 5.27 9 WLPVYNAQVVAAYR 130-143 Cytoskeleton, muscle contraction 
 Neurofibromatosis 1 6981264 316.9 1.84 3 SYKYLLLSMVK 488-498 Cytoskeleton, tumor suppressor protein 
 NADH dehydrogenase 
(Ubiquinone) Fe-S 
9506913 12.8 29.31 4 TGTCAYCGLQFK 101-112 Mitochondria, NADH reduction and 
oxydation 
34 months old 
rat cardiac 
tissue 
Myosin-5C 109483639 202.2 3.24 3 FAESKLIYTYSGILVAMNPYK 91-111 Cytoplasmic, organelle transport 
 Myosin heavy chain 
polypeptide 6 
8393804 223.4 5.68 7 ERYAAWMIYTYSGLFCVTVNPYK 106-128 Cytoskeleton, converts chemical energy into 
mechanical energy through the hydrolysis of 
ATP 
 Tropomyosin 1, α isoform e 78000196 32.7 44.72 16 YEEEIK 221-226 Cytoskeleton, muscle contractionthrough the 
tropomyosin-troponin-Ca2+system. 
 Neurofibromatosis 1 
(Neurofibromin) 
6981264 316.9 1.17 6 SYKYLLLSMVK 488-498 Cytoskeleton, tumor suppressor protein 
 Cadherin EGF-LAG seven 
pass G-type receptor 2 
22095545 220.0 1.88 2 EPCENYMRCVSVLR 460-473 Cell membrane, cell adhesion mediator 
 Dynein, cytoplasmic, heavy 
chain 1 
31377489 531.9 0.34 3 QLTAYMK 665-671 Cytoplasm, cytoplasmic motor transport 
protein that propels membrane organelles 
towards (-) ends of polarized microtubules 
through ATP hydrolysis 
 Nebulin-related anchoring 
protein isoform C (N-RAP) 
109468170 771.7 0.57 9 EYRKDLEESIR 5968-5978 Cytoskeleton, thin filament length and 
assembly regulation 
 Cys2/His2 Zn finger protein 
(rKr1) 
21426789 73.8 6.00 5 LLIKEGQYK 282-290 Nucleus, transcriptional regulator 
 Myosin heavy chain 
polypeptide 7 
8393807 222.9 16.33 17 WLPVYNAQVVAAYR 130-143 Cytoskeleton, muscle contraction 
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Glu106-Lys128 (Figure 3.4) from myosin heavy chain polypeptide 6 (GenInfo 
accession number 8393804), nitrated at both Tyr114 and Tyr116, the nitrated peptide 
 
Figure 3.4 Representative MS/MS spectrum of myosin heavy chain polypeptide 6. 
Displayed here is the MS/MS spectrum of the nitrated peptide sequence Glu106-Lys128 detected for 
myosin heavy chain polypeptide 6, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we 
have highlighted the b-ions covered in the series, b3-b14. 
 
Tyr221-Lys226 (Figure 3.5) from tropomyosin 1, α isoform e (GenInfo accession 
number 78000196), nitrated at Tyr221,  the nitrated peptide Ser488-Lys498 (Figure 3.6) 
from neurofibromatosis 1 (neurofibromin) (GenInfo accession number 6981264), 
400 600 800 1000 1200 1400 1600 1800
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
n
da
n
ce
924.3
1037.3
777.2
1145.3
664.1 1258.3
998.1
755.1
1747.0
885.1
827.1
1240.3
440.2 541.0296.4
1681.7357.6
b5+2
449.2
b3
b4
688.0
b16+3
b19+3
b6
849.9
b13+2
906.4
b14+2
b7
979.9
b15+2
b8
1031.5
b16+2
1081.0
b17+2
1286.6
b21+2
y18+2
818.9
y14+2
768.4
y13+2
y12+2
520.2
592.3
y10+2
512.6
y13+3
y9+3
a 7
+
2 -
N
H
3
b 1
3-
N
H
3
b 1
4-
SO
CH
4
z14
+2
a 1
3+
2 -
N
H
3
y 2
2+
3 -
SO
CH
4-
H
2O
-
N
H
3
[Y
(N
O
2)S
G
LF
CV
TV
-
H
2O
]
y 2
1+
2 -
SO
CH
4-
2H
2O
-
N
H
3
y 2
1+
2 -
SO
CH
4-
N
H
3
E   R   Y  A   A   W   M I   Y T   Y S   G   L  F   C  V   T   V   N   P   Y   K
b1     b2     b3 b4 b5 b6      b7 b8    b9     b10   b11 b12  b13   b14  b15   b16  b17   b18     b19 b20 b21 b22
y22  y21  y20 y19 y18 y17  y16 y15  y14  y13    y12  y11   y10   y9    y8  y7    y6     y5       y4     y3  y2 y1
A
AW
M I
Y(NO2)TY(NO2)SG
L
1582.4
y 1
4-
3H
2O
R
el
at
iv
e 
A
bu
n
da
n
ce
a 7
+
2 -
N
H
3
b 1
3-
N
H
3
b 1
4-
SO
CH
4
a 1
3+
2 -
N
H
3
y 2
2+
3 -
SO
CH
4-
H
2O
-
N
H
3
[Y
(N
O
2)S
G
LF
CV
TV
-
H
2O
]
y 2
1+
2 -
SO
CH
4-
2H
2O
-
N
H
3
y 2
1+
2 -
SO
CH
4-
N
H
3
y 1
4-
3H
2O
 46 
nitrated at Tyr491, the nitrated peptide Phe91-Lys111 (Figure 3.7) from Myosin-5C 
(GenInfo accession number 109483639), nitrated at both Tyr98 and Tyr100, the nitrated  
 
Figure 3.5 Representative MS/MS spectrum of tropomyosin. 
Diplayed here is the MS/MS spectrum for the nitrated peptide sequence Tyr221-Lys226 detected for 
tropomyosin, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we have highlighted the 
b-ions covered in the series, b2-b6. 
 
peptide Glu460-Arg473 (Figure 3.8) from Cadherin EGF-LAG seven pass G-type 
receptor 2 (GenInfo accession number 22095545), nitrated at Tyr465, the nitrated 
peptide Gln655-Lys671 (Figure 3.9) from Dynein heavy chain1 (GenInfo accession 
number 31377489), nitrated at Tyr659, the nitrated peptide Leu282-Lys290 (Figure 3.10) 
from Cys2/His2 Zn finger protein (GenInfo accession number 21426789), nitrated at 
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Tyr289, and finally, the nitrated peptide Trp130-Arg143 (Figure 3.11) from Myosin 
heavy chain polypeptide 7 (GenInfo accession number 8393807), nitrated at both 
Tyr134 and Tyr142.  
 
 
 
 
Figure 3.6 Representative MS/MS spectrum of neurofibromin. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Ser488-Lys498 detected for 
neurofibromin, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we have highlighted the 
b-ions covered in the series, b2-b10. 
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Figure 3.7 Representative MS/MS spectrum of Myocin-5C. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Phe91-Lys111 detected for 
Myocin-5C, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we have highlighted the b-
ions covered in the series, b5-b7 and the internal fragment b5-b12 containing both nitrated Tyr98 and 
Tyr100. 
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Figure 3.8 Representative MS/MS spectrum of cadherin EGF-LAG seven pass G type receptor 2. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Glu460-Arg473 detected for 
cadherin EGF-LAG seven pass G-type receptor 2, in cardiac tissue of 34 months old Fisher 344 BN-F1 
rats. Here we have highlighted the y-ions covered in the series, y5-y9. 
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Figure 3.9 Representative MS/MS spectrum of dynein. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Gln665-Lys671 detected for 
dynein, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we have highlighted the y-ions 
covered in the series, y2-y4. 
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Figure 3.10 Representative MS/MS spectrum of Cys2/His2 Zn finger protein (rKr1). 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Leu282-Lys290 detected for 
Cys2/His2 Zn finger protein (rKr1), in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we 
have highlighted the b-ions covered in the series, b3-b8. 
 
 
 
 
200 300 400 500 600 700 800 900 1000 1100
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
la
tiv
e
 
Ab
u
n
da
n
ce
910.3669.2
455.8
797.4
911.4
226.9 670.3
779.7
903.3
553.3
512.2
442.2
798.4
438.2
991.3424.3 832.3389.9
198.9
305.2
893.0
560.9227.8
695.0 1008.1
892.1
651.3
505.4
1023.9
876.0
763.1325.9 605.8 761.5
973.1
355.2
y2
540.2
y4
y5
y6
y7
y8
y8+2
y7+2
399.2
y6+2
242.1
y3+2
234.7
b4+2
391.7
b7+2
b2
340.3
b3
468.4
b4
782.5
b7
990.5
b8
b5-CO2
y6-H2O
b8-3NH3-2H2O
a2
LI
a6
+2
-NH3
y6+2-H2O
y7+2-H2O-NH3
EGQY-H2O
y5-H2O y6-2NH3
y7-NH3
y7-H2O
y7-2NH3 b8+H2O
L  L  I  K  E  G  Q  Y K
y8 y7 y6       y5 y4        y3         y2        y1
b1     b2     b3       b4       b5        b6        b7 b8
I K E GQ Y(NO2)
Re
la
tiv
e
 
Ab
u
n
da
n
ce
Re
la
tiv
e
 
Ab
u
n
da
n
ce
 52 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Representative MS/MS spectrum of myosin heavy chain polypeptide 7. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Thr130-Arg143 detected for 
myosin heavy chain polypeptide 7, in cardiac tissue of 34 months old Fisher 344 BN-F1 rats. Here we 
have highlighted the y-ions covered in the series, y5-y13. 
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It is interesting to note that several of the nitrated proteins detected after 
solution IEF are located in the cytoskeleton, whereas our previous 2DE experiments 
(5), localized many nitrated cardiac proteins to the mitochondria. This difference 
between the nature of identified proteins via two independent methods reflects, again  
a phenomenon commonly observed during proteomic experiments, where different 
techniques lead to the identification of different subsets of proteins (13). 
Significantly fewer (a total of three) nitrated proteins were detected in the 
analysis of cardiac tissue from young (5 months old) rats (Table 1). Here, only 
NADH dehydrogenase was not detected in the heart of old (34 month) rats, whereas 
both myosin heavy chain polypeptide 7 and neurofibromin were also detected in the 
aging heart. Figure 3.12 displays a representative MS/MS spectrum for the nitrated 
peptide Thr101-Lys112 from NADH dehydrogenase (GenInfo accession number 
9506913), nitrated at Tyr106. 
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Figure 3.12 Representative MS/MS spectrum of NADH dehydrogenase (ubiquinone) Fe-S. 
Displayed here is the MS/MS spectrum for the nitrated peptide sequence Thr101-Lys112 detected for 
NADH dehydrogenase (ubiquinone) Fe-S, in cardiac tissue of 5 months old Fisher 344 BN-F1 rats. 
Here we have highlighted the y-ions covered in the series, y2-y9. 
 
3.4 Discussion/Conclusion 
 NO plays an important role in signal transduction to regulate proper cardiac 
muscle function (14,15). NO specifically integrates cell system responses by 
controlling oxygen supply and demand, especially during an ischemic attack (15). NO 
regulates proper hemoglobin function and cardiac smooth muscle contractility to 
coordinate the respiratory cycle in order to ensure proper oxygen delivery to target 
tissues (15-17). Therefore, cardiac muscles are periodically exposed to fluxes of 
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an environment amenable for the formation of peroxynitrite (ONOO-), a major 
nitrating species (19), through the diffusion controlled reaction of NO and superoxide 
(20). Therefore, the formation of nitrated proteins in cardiac muscle is not unexpected. 
Importantly, aging leads to an accumulation of nitrated proteins, which may affect 
cardiac function (5). This accumulation may be, in part, an indication of an age-
dependent slower proteasomal degradation of nitrated proteins (21), higher 
concentrations of nitrating species (5), and/or slower repair by the putative protein 
“denitrase” (22,23) (or a combination of all three parameters). We note that 
peroxynitrite is not the only reagent which can nitrate proteins in vivo, but that other 
nitrating species, such as nitrogen dioxide (.NO2), may be involved as well. 
 Tyrosine nitration can affect protein structure and function. The magnitude of 
such effect will primarily depend on the location of 3-NY within the protein and its 
quantity. Densitometry measurements quantify a ca. 1.5-2.0 fold overall age-
dependent increase in protein nitration. The location of 3-NY within the detected 
proteins has been addressed in this study through the MS/MS analysis of individual 
nitrated peptides. Quantitation of 3-NY within each of the individual target proteins 
by our mass spectrometric method was not possible. Such quantitation and 
experimental proof of potential functional and structural consequences of nitration 
will be part of future studies focusing on the targeted purification of the proteins 
identified in the present study. In the following we will provide a discussion of the 
potential effects of tyrosine nitration within these peptide sequences.  
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Some of the more interesting nitrated proteins detected in this work are 
located in the cytoskeleton, namely myosin, N-RAP (isoform C), tropomyosin, and 
neurofibromin. For myosin, we detected nitration at Tyr114 and Tyr116 for polypeptide 
6, and nitration at Tyr134 and Tyr142 for polypeptide 7. It has been observed that an 
age-dependent slower muscle movement is due to functional and structural changes 
of myosin, in particular the heavy chain (24). This is important to note, especially in 
view of the slow turnover rate, and decreased rate of synthesis and degradation of this 
protein (24). The myosin heavy chain converts chemical energy, present in the form 
of ATP, into mechanical energy (25). Therefore, structural changes that can affect the 
normal function of these proteins may explain the age dependent loss of muscle force 
and contractile speed (24). Figure 3.13 displays a cartoon locating the 3-NY residue 
within these protein sequences of myosin polypeptides. 
 To date, relatively little information is available about the functional roles of 
N-RAP (isoform C). It has been proposed that N-RAP anchors the terminal actin 
filaments in the myofibril to the membrane as well as transmits the tension from the  
 
Figure 3.13 Cartoon displaying the relative location for the nitrated peptides of myosin heavy 
chain that were found in the present study.  
In this cartoon, we display the whole myosin complex, composed of two heavy chains, and two light 
chains. The two heavy chains are shown in gray, and the light chains that wrap around the neck of the 
two myosin light chains are shown in black. The 3-NY modification is located in the head region of the 
myosin heavy chain. 
3-NY
Myosin heavy chain
3-NY
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myofibrils to the extracellular matrix. N-RAP is specifically expressed in skeletal and 
cardiac muscles (26,27). The N-RAP super repeats have been shown to bind actin 
very tightly analogous to nebulin. This suggests that N-RAP binding to actin 
filaments is a highly cooperative process, which leads to the transmission of the 
tension created during myofibril contraction and relaxation. N-RAP displays a 
sequence homology to the C-terminal half of nebulin, as well as the LIM domain (a 
Cys rich domain, that can bind to two Zn ions) at the N-terminus, responsible for 
mediating protein-protein interactions (27). Figure 3.14 shows a cartoon indicating 
that the nitration of N-RAP targets specifically the C-terminal domain involved in 
actin binding. 
 
 
Figure 3.14 Cartoon displaying the relative location for the nitrated peptide of nebulin-related 
anchoring protein (N-RAP) found in the present study. 
N-RAP is composed of three distinct regions. The LIM-domain, nebulin like simple repeats domain 
and the actin binding domain. The 3-NY modification is located at the actin-binding domain of N-RAP.   
 
Tropomyosin regulates the interactions between actin and actin-binding 
proteins (28). Tropomyosin 1 represents the predominant isoform present in the 
cardiac muscle and fast skeletal muscle fibers. Mutations of the TPM1 gene (which 
encodes for Tropomyosin 1), result in different types of myopathies causing abnormal 
3-NYLIM-Domain Actin binding domain, Nebulin related super repeatsNebulin like simple repeats
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muscle function (28,29). Figure 3.15 shows a cartoon locating the 3-NY residue 
within the protein sequence of Tropomyosin. 
 
 
Figure 3.15 Cartoon displaying the reported shape of this protein and the relative location for 
the nitrated peptide of tropomyosin found in the present study.  
The 3-NY modification in this protein is located towards the C-terminus of its amino acid sequence. 
 
 Neurofibromin, encoded by the gene NF1, represents a tumor suppressor 
protein which acts as a negative regulator of Ras. Mutations to NF1 or the absence of 
the NF1 gene can cause congenital heart disease associated with neurofibromatosis 
type 1, e.g. benign neurofibromas, leukemias and multiple cardiac abnormalities (30). 
These disorders likely depend on an unregulated Ras signaling pathway, which may 
stimulate cell growth or inhibit apoptosis. The 3-NY491 residue in this protein is 
located very close to a mutation site, Tyr489, commonly found in genetic studies of 
patients suffering neurofibromatosis type 1 (31). Nitration of Tyr491 may have a 
similar negative effect on the protein as mutation to Tyr489 within the same protein 
domain. Figure 3.16 displays a cartoon locating the 3-NY residue within the protein 
sequence of neurofibromin. 
 
3-NY
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Figure 3.16 Cartoon displaying the relative location for the nitrated peptide of neurofibromin 
found in the present study.  
This protein is being shown in its denatured form. The 3-NY modification in this protein is located 
towards the N-terminus of its amino acid sequence. 
 
 Some of the other nitrated proteins identified in this work (Table 3.1) play 
important roles in cellular function, such as for example, organelle transport by 
myosin 5C, cell membrane adhesion regulation by cadherin EGF-LAG seven pass G-
type receptor 2, and transcriptional regulation in the nucleus by the Cys/His Zn-finger 
protein. The modifications to these proteins together with the cytoskeletal proteins 
already discussed, may offer some rationale for cardiac dysfunction, though it can be 
expected that additional nitrated proteins may be detected in the heart as more 
sensitive proteomic methods become available.  
Some oxidized and nitrated proteins are susceptible to accelerated turnover 
(32,33), while others tend to accumulate (34,35). Our earlier (5) results suggest a 
rather selective accumulation of a few nitrated cardiac proteins. In addition to 
selective turnover, other parameters such as cellular location, protein structure, and 
protein-protein interactions, will define the susceptibility to nitration (34). The target 
proteins that we have identified in this work serve as evidence for age dependent 
3-NY
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protein nitration in-vivo. Future studies must now focus on a targeted isolation of 
identified proteins to quantitate age-dependent nitration, the possible accumulation of 
additional modifications, and to correlate these modifications with protein function. 
In collaboration with Dr. Stobaugh and members of his group, we have taken a step 
forward to achieve this goal. A fluorogenic derivatization method specific for 3-NY 
and hydroxytyrosine has been developed and it has been shown to work well for 
small molecules and peptides (36). In the next chapters of this thesis, we will discuss 
how this new derivatization method has been successfully applied to the protein 
Calmodulin (CaM).   
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4. Fluorogenic derivatization of 3-Nitrotyrosine residues in Calmodulin with  4-
aminobenzylbenzene sulfonic acid 
 4.1 List of abbreviations used inside the text 
      - ROS: Reactive oxygen species 
      - RNS: Reactive nitrogen species 
      - CaM: Human Calmodulin, UniProtKB/Swiss-Prot entry P62158, MW      
 16706.4 Da 
      - NaBH4: Sodium Borohydride 
      - Ni/Pt: Nickel/ Platinum Catalyst 
      - K3Fe(CN)6: Potassium Ferricyanide 
      - ABS: 4-aminobenzylbenzene sulfonic acid 
      - 3-NY: Nitrotyrosine 
      - 3-AY: Aminotyrosine 
      - K: Lysine 
      - TNM: Tetranitromethane 
      - ICAT: Isotope-Coded Affinity Tag 
      - PMA: Phenymethylamine 
      - PBO: 2-phenylbenzoxazole 
 
4.2 Introduction 
Protein nitration leads to a chemically stable protein modification and the 
accumulation of nitrated proteins in tissue may define the phenotype for biological 
aging or any pathology. Most of the nitrated proteome in literature has qualitative 
data and quantitative measurement remains a challenge since a lot of nitrated proteins 
in-vivo have low abundance and usually fall below the detection limits of currently 
available quantitative methods (1).  
Some of the most commonly applied methods for 3-NY proteomics are 
antibody based methods, such as Western blot analysis (2-5), enzyme-linked 
immunosorbent assay (ELISA) (6-8), and immunoprecipitation (4,9). All these have 
relied on monoclonal anti-3-NY antibodies, which are known to recognize only a 
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subset of nitrated epitopes (10) which, may explain low reactivity in some samples. 
Anti-body techniques are mostly qualitative and sometimes, may be used semi-
quantitatively because they don’t provide information on total protein content, only 
on the levels of 3-NY. Therefore, these antibody based techniques are usually used in 
conjunction with 1D and 2D gel electrophoresis. 1D gel electrophoresis separates 
proteins in the sample by molecular mass, therefore used as a size exclusion 
technique to simplify complex samples. Also, 1D gel electrophoresis offers some 
quantitation by protein staining although, this is dependent on the dynamic range of 
the protein stain used, usually Coomassie blue or Silver staining for higher sensitivity.  
2D gel electrophoresis separates proteins according to their pI in the first dimension 
and size in the second dimension, offering a protein map also amenable for some 
quantitation by protein staining in the same way as 1D gel electrophoresis. The only 
drawbacks of these in-gel techniques are that total protein loads are limited and for 
2D gels, it has been shown that they are biased against highly hydrophobic, low 
abundance and high molecular weight and extreme pI proteins (11).  
Lack of absolute quantitative techniques for the study of protein Tyr nitration 
have driven the inspiration for the set of experiments described in this and the 
following chapters. In collaboration with Dr. Stobaugh and his group, our lab has 
developed a novel derivatization technique specific for nitrotyrosine (3-NY) after 
amino reduction to aminotyrosine (3-AY) and hydroxytyrosine (DOPA), that is 
amenable for quantitation by both fluorescence spectroscopy and mass spectrometry 
analysis of derivatized 3-NY in the samples with isotope coded tags, an approach 
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similar to the isotope coded affinity tag (ICAT) derivatization technique (12). Since 
the focus of this thesis is on 3-NY, we will focus on the derivatization of 3-NY.  
It has been previously reported that a selective fluorogenic derivatization of 
ortho-substituted phenol derivatives such as hydroxytyrosine (DOPA) and 3-NY after 
nitroreduction to 3-AY with benzylamine yields a 2-phenylbenzoxazole (PBO)  
product (Figure 4.1) (12). After further investigation and experimentation with 
biological macromolecules, i.e., peptides such as Angiotensin I and proteins such as 
Phosphorylase b, the need for a more water soluble tag became apparent and a 
slightly modified version of PMA with a sulfonic acid moiety was synthesized in our 
lab by Dr. Xiabao Li. The new tag was called 4-(aminomethyl)benzene sulfonic acid 
(ABS) (Figure 4.2). 
 
 
 
Figure 4.1 Catechol reaction with benzylamine to yield the 2-phenylbenzoxazole product (1). 
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Figure 4.2 Synthesized (aminomethyl)benzene sulfonic acid (ABS). 
This is a more water soluble version of benzylamine to be used as the derivatization agent in reactions 
with biological molecules. 
 
The derivatization reaction of 3-NY with ABS after nitroreduction to 3-AY 
were conducted in phosphate buffer with high molar excess of the tagging reagent to 
analyte and differing iron concentrations in the form of potassium ferricyanide 
(K3Fe(CN)6). Fluorescence after derivatization was evident however, the fluorescent 
products were not well characterized by mass spectrometry. Therefore, a peptide 
model system was developed by synthesizing a partial sequence of muscle 
phosphorylase b (PhB) with a nitrated Tyr residue, 545FSAY(NO2)LER555 (13). 
Experimentation with this PhB peptide and ABS yielded two different PBO 
derivatives that were formed depending on the reaction conditions, more specifically, 
they were found to be dependent on the iron concentration used for the derivatization 
reaction (13). Figure 4.3 shows the structure of the two derivatization products from 
the reaction of 3-NY with ABS.  
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Figure 4.3 Structure of the two derivatization products identified with model peptide studies. 
(A) is the product with one ABS tag attached and (B) is the product with two ABS tags attached to the 
nitrated Tyr residue. 
 
Since well characterized products were not observed when working with full 
protein PhB, a relatively large protein (194kDa) found to be nitrated both in-vitro and 
in-vivo on multiple Tyr residues (14), in this study, we wanted to investigate if we 
could characterize ABS labeling on a full protein using a simpler model protein. For 
this purpose, we chose Calmodulin (CaM) as our model protein to apply the ABS 
tagging method. CaM is a relatively small protein (16706.4 Da) and it only contains 2 
Tyr residues at positions 99 and 138. This is a ubiquitous Ca2+ binding protein that is 
very important for cellular regulation as presented by Cheung et. al. in Figure 4.4 (15). 
The calcium ion Ca2+is very important for regulation of biological processes such as 
muscle contraction, cellular motility, endocytosis and exocytosis (15). This protein 
lacks Cys residues and hydroxyproline, which contributes to its high flexibility to 
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assume a tertiary structure able to interact with its many Ca2+ dependent receptor 
proteins. Inactivation of this protein by oxidation thus, would disrupt the Ca2+ 
homeostasis resulting in cellular imbalance and potentially cell death (15). 
 
Figure 4.4 This figure was extracted from Cheung’s 1980 article , to illustrate the magnitude of 
CaM important presence in  cellular regulation (15). 
 
CaM has been shown to be highly susceptible to nitration by 
tetranitromethane (TNM), peroxynitrite (ONOO-), and hydrogen peroxide (H2O2) in-
vitro (16-19). TNM in the presence of Ca2+ has been shown to effectively nitrate both 
Tyr residues in this protein (19,20), providing a simple model to study the 
derivatization reaction with ABS on a system where secondary and tertiary structures 
are present. Through this study, we found the presence of the two products previously 
observed with model peptide FSAY(NO2)LER, the addition of 1 ABS molecule 
(Tyr+196) and the addition of 2 ABS molecules (Tyr+366) (2,3) as presented in 
Figure 4.3, with good MS/MS evidence. In addition, we found a third product 
involving an intra-molecular cross-link of Lys (K) with the derivatized Tyr residue 
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(Tyr +179). This lead us to a deeper understanding of this ABS tagging method and 
conclude that any primary amine in close proximity to the Tyr residue of interest 
could serve to activate the first step of the reaction involving the C5 of the aromatic 
6-membered ring in aminotyrosine (3-AY), as shown in the reaction Scheme in 
Figure 4.5. 
4.3 Experimental 
Materials 
For CaM overexpression, BL21(DE3) cells were purchased from Novagen (La 
Joya, CA). 3-(N-morpholino)propanesulfonic acid (MOPS), M9 media components, 
tetranitromethane (TNM), ethylene diamine tetraacetic acid (EDTA), potassium 
ferricyanide (K3Fe(CN)6), sodium borohydride (NaBH4), hydrazine hydrate, cetyl 
methylammonium bromide (CTAB), chloroplatinic acid and nickel sulfate were 
purchased from Sigma-Aldrich (St. Louis, MO). Pre-cast 4-20% SDS-PAGE gels  
and 10DG Desalting columns were purchased from Bio-Rad (Hercules, CA), protein 
assay Bradford Reagents were purchased from PIERCE (Rockford, IL). Amicon 
Ultra-15 centrifugal filter units with Ultracel-3 membranes were purchased from 
Millipore (Billerica, MA). 4-aminobenzylbenzene sulfonic acid (ABS) was 
synthesized in house by Dr. Xiabao Li. De-ionized distilled water was filtered by a 
Labconco purification system (Kansas City, MO). Tris-Glycine SDS 2X sample 
buffer was purchased from Invitrogen (Carlsbad, CA). Tris-HCl, potassium hydroxide 
(KOH) and sodium phosphate (Na2HPO4) and sequencing grade trypsin were 
purchased from Fisher Scientific (Pittsburg, PA). 
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Figure 4.5 Reaction scheme for 3-NY derivatization with ABS fluorescent tag.  
Reaction involves first reduction of nitro group in 3-NY to an amino group to 3-AY. This step is 
followed by oxidation by K3Fe(CN)6 and Michael addition of species containing primary amine at C5 
on the aromatic ring of Tyr. Then, a second oxidation step takes place and finally, one ABS tag 
molecule is added to the Tyr of interest. 
 
CaM expression 
CaM overexpression was achieved by transformation of the recombinant 
plasmid containing the gene encoding CaM (generously provided by Eric Gorman 
and Dr. Yunsong Li from the Department of Pharmaceutical Chemistry at the 
University of Kansas) into BL21(DE3) cells (Novagen, La Joya, CA). Transfection 
was done according to the manufacturer’s protocol and overexpression was done at 
 
R     NH2 is any primary amine
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37oC in M9 minimal media , essentially following the protocol previously described 
by Li et. al (21). 
CaM purification 
CaM was purified both from transfected (i)BL21(DE3)-T1R competent E. coli 
cells purchased from Sigma (St. Louis, MO) , generously provided by Eric Gorman, 
University of Kansas, and (ii) Novagen BL21(DE3) cells which we transfected in our 
laboratory.  The cells were washed and re-suspended in MOPS buffer prior to lysing 
them using a French press. The lysed cells were centrifuged and the supernatant was 
collected and loaded onto an ÄKTA FPLC system (Amersham Biosciences, 
Piscataway, NJ) with a pre-equilibrated (50 mM Tris-HCl, pH 7.5, 1mM CaCl2) 
XK26 (26 mm i.d. x 10 cm) column (GE Healthcare Bio-Sciences Corp., Piscataway, 
NJ) packed with Phenyl–Sepharose. After a few washes with equilibration buffer, 
CaM was eluted with 10 mM Tris-HCl, pH 7.5 and 10 mM EDTA. The peak 
containing CaM was collected into ~twelve 1 ml fractions and concentrated using an 
Amicon Ultra-15 centrifugal filter unit with an Ultracel-3 membrane (21,22). At the 
final centrifugation step, the protein was buffer exchanged into 50 mM Tris, pH 8, 
and stored at -80 oC until used. 
CaM Nitration 
A stock solution of TNM was washed by 3 water extractions. Then, an 840 
mM stock solution of TNM in Ethanol was prepared and stored at 3 oC. After 
determining protein concentration of the CaM stock solution using the Bradford 
Reagent method, 300 µl of stock protein solution were added to 2700 µl of nitration 
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buffer composed of 50 mM Tris, pH8 and 5mM CaCl2. We added Ca2+ to our 
nitration buffer because previous studies have shown that in the absence of Ca2+ 
Tyr138 is more susceptible to nitration by TNM than Tyr99. However, in the presence 
of Ca2+, both nitration of Tyr99 and Tyr128 can be achieved (19,20). For the nitration 
reaction, we calculated a 50X molar excess of TNM to tyrosine. The reaction mixture 
was stirred vigorously for 1hr at 25oC. The nitrated protein was then cleaned up using 
a 10DG desalting column by gravity filtration. Eight 1 ml fractions were collected 
from the desalting column and each one was tested for the presence of nitrated CaM 
by scanning the absorbance from 200 to 600 nm using a Cary 50 UV 
spectrophotometer. Only the fractions giving an absorbance at 280 and ~430 nm were 
pooled and saved. After pooling the fractions, an absorbance scan was performed 
again to determine the 3-NY content, by diluting 50 µl of sample in 0.1% NaOH and 
taking into account the dilution factor and using the extinction coefficient for 3-NY 
ɛ=4400 M-1cm-1 (Conc. of 3-NY=(Abs at 430nm/4400)x(dilution factor)) (23). Once 
our 3-NY content was established, we measured our total protein concentration in the 
nitrated sample and determined that we had ~0.67 mol 3-NY per mol of CaM.  
Synthesis of Ni/Pt Catalyst 
The protocol for synthesis of the Ni/Pt catalyst used for 3-NY reduction to 3-
AY prior to fluorogenic labeling with ABS was obtained from Jacque Killmer’s PhD 
Thesis. A 5 ml solution of 14 mM nickel sulfate (Sigma, St Louis MO), 580 µM 
chloroplatinic acid, and 100 mM cetyl methylammonium bromide (CTAB) was 
purged with nitrogen gas for 5 min. The solution was sealed and stirred magnetically 
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for 30 minutes at room temperature. Then, 30 µl of hydrazine hydrate (Sigma, St 
Louis MO), and 200 µl of 50% KOH, in water were added to the reaction mixture and 
continued to stir at room temperature until the solution turned black. The reaction 
mixture was transferred to 15 ml centrifuge tubes. Step one of particle recovery was 
to centrifuge the reaction mixture at 5000g for 2 to 5 minutes. Step two was to 
remove the supernatant and washing the particles 10 times with water repeating steps 
one and two. After the final wash, the particles were dried in a centrivap (model no. 
7810000, Labconco, Kansas City, MO) and stored for future use. 
CaM 3-NY reduction to 3-AY 
A water suspension was made that contained 500 µg/ml of Ni/Pt particles. For 
the 3-NY reduction step, the concentration of NaBH4 was adjusted to be 200 mM in 
the reaction mixture and 5 µl of Ni/Pt catalyst solution were added per 300 µl of 
reaction volume. The reaction mixture was vortexed and incubated at 37 oC for 1hr. 
Then, the reaction was quenched by the addition of hydrochloric acid (HCl), to have a 
final concentration of 200mM HCl in the reaction. The protein was precipitated from 
the reaction mixture by the addition of excess EtOH and incubating the solution at -20 
oC overnight. The precipitated proteins were collected by centrifugation at 13000g in 
a microcentrifuge. 
Tagging Reaction 
Protein concentration in the 3-AY containing CaM sample was measured by 
the Bradford reagent method and adjusted to 10 µM. This protein solution was 
aliquoted into 400 µl volumes for the ABS tagging reactions. For the control samples, 
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we also had 10 µM 3-NY containing CaM sample and a 10 µM native CaM sample, 
also at 400 µl.  To check protein concentration in each sample after adjustment we 
run an SDS-PAGE gel of the 3-NY, 3-AY, and native CaM samples, Figure 4.6.  
 
Figure 4.6 SDS-PAGE  gel of native, nitro-
reduced and in-vitro nitrated CaM stained 
with coomassie blue.  
We can see that our protein normalization for 
protein concentration is good. All the samples, 
controls and reactions have the same protein 
concentrations.  
 
In the first set of experiments, we tested the effects of iron concentration in 
the reaction since it was previously shown with a model peptide FSAYLER (13) that 
iron concentration had an important role in the fluorescence and formation of the 
right fluorescent products after derivatization, having either one tag molecule reacting 
with 3-AY or two tag molecules reacting with 3-AY (Figure 4.3). The source of iron 
in our reactions was from K3Fe(CN)6. All reactions were done in 100 mM phosphate 
at pH 9. 
The second set of experiments was to determine the limit of detection of 3-NY 
for our derivatization. For this purpose, the 10 µM 3-AY CaM sample was serially 
diluted into 10 µM native CaM sample to achieve different 3-AY concentrations in 
our samples without affecting the total protein concentration.   
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Fluorescence Characterization 
Fluorescence characterization of each tagged sample was done using a 
fluorescence spectrophotometer (RF 5000U Shimadzu, Japan). Both excitation and 
emission wavelengths were determined using a 400 µl fluorescence quartz cuvette. 
Samples were diluted 50 times in 100 mM Phosphate, pH 9 in order to obtain 
readings within the instrument’s data window. Excitation for ABS labeled 
compounds was found to be 360 nm and the emission was found to be 480 nm, Figure 
4.7.  
 
 
 
 
 
 
 
 
Figure 4.7 Exitation and emission wavelengths of ABS tagged CaM.   
 
Gel electrophoresis 
Derivatized proteins, using different iron concentrations, were submitted to SDS-
PAGE on 4-20 % Tris-HCl pre-cast gels. 25 µl of each sample were diluted with 2X 
sample buffer for a total volume of 50 µl. The gel was run at 200 V for 35 minutes. 
 
300 350 400 450 500 550 600
Wavelength (nm)
EX 360               EM480
 77 
The gels were removed from their casing and placed under a hand held UV lamp, 
Figure 4.8 (Model UVL-56 115 V, 60 Hz, 0.16 A, UVP, Inc., San Gabriel, CA 
91778). The fluorescent bands were cut out and followed by in-gel trypsin digestion 
(24). The trypsin digests were then submitted for MS/MS analysis. 
 
 
 
 
 
 
 
 
 
Figure 4.8 SDS-PAGE of ABS tagged CaM. 
Here, reactions were done in the presence of different iron concentrations (K3Fe(CN)6). Here, we can 
observe that the controls do not have any fluorescence. 
 
In-gel trypsin digestion 
  The excised gel bands were first crushed into smaller pieces and 200 µl of 
pure MeCN were added to dehydrate the gel pieces. Then, 2 µg of trypsin were added 
to each sample in ~ 50 to 60 µl of 50 mM NH4HCO3 and incubated at 37oC overnight. 
The digested protein samples were saved for mass spectrometry analysis with the FT-
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ICR mass spectrometer available in the Multidisciplinary Research Building (MRB) 
here at the University of Kansas.  
Mass Spectrometry Analysis 
Full protein MS analysis was performed on a Q-TOF-LCMS instrument by Dr. 
Todd Williams and Mr. Bob Drake at the University of Kansas Mass Spectrometry 
Lab. The MS data analysis was done using Mass-Lynx 3.5 software (Micromass, UK). 
The multiply charged spectrum obtained from the mass spectrometer was transformed 
to a full protein, uncharged spectrum using this software. This full protein spectrum 
was used for analysis of full protein derivatization data. 
Peptide MS/MS were performed on an LTQ-FT hybrid linear quadrupole ion 
trap Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer 
(ThermoFinnigan, Bremen, Germany) via capillary liquid chromatography by Dr. 
Nadezhda Galeva at the University of Kansas.  Prior to MS and MS/MS analysis, 
peptides were separated by reversed phase chromatography. The raw acquisition data 
was processed by BioWorks 2.2 software (Thermo Scientific, Waltham, MA) 
followed by peptide/protein identification using Sequest (Thermo Finnigan) and 
Mascot (Matrix Science, Boston, MA) and X!Tandem (The Global Proteome 
Machine Organization) database-searching programs. The MS/MS spectra were then 
validated by Scaffold 1.7 (Proteome Software Inc., Portland Oregon), a software that 
operates on a statistical method by setting confidence thresholds to the data obtained.  
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4.4 Results 
 The fluorescent tagging method was very efficient. Samples were observed to 
fluoresce just 30 seconds after adding the tagging reagent to the sample. In the iron 
dependence experiment, we found that there was an optimal concentration of iron 
needed in order to have maximum fluorescence. If iron concentration falls below or 
exceeds this optimal concentration, fluorescence yields were observed to decrease.  
Five different iron concentrations were tested and the optimal conditions for 
maximum fluorescence was observed to be 120 X molar excess to 3-NY present in 
the sample as observed in Figure 4.9. However, from studies done previously on the 
model peptide FSAY(NO2)LER, the best ratio of iron to 3-NY was a 30X molar 
excess of iron, to arrive at the desired products as identified by RP-HPLC and mass 
spectrometry (3). 
 
 
 
 
 
 
 
 
Figure 4.9 CaM samples tagged with 200 mM ABS and different K3Fe(CN)6 concentrations.  
As observed with studies done with the model peptide FSAY(NO2)LER (3), there was an optimal 
concentration of iron for maximum fluorescence, in this case, 120X to 3-NY. 
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We also tested the tagging reaction’s limit of detection by diluting the 3-NY 
content in the samples and keeping the total protein concentration constant, and the 
iron ratio of 30X molar excess. The concentrations of 3-NY tested were 0.3 µM , 1.3 
µM , 2.3 µM , and 3.3 µM . We observed a linear response in fluorescence to the 3-
NY content in the samples (Figure 4.10). However, for full protein detection of 
tagged protein derivatives by mass spectrometry, 3.3 µM 3-NY in the samples was 
needed. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Fluorescence emission was linearly dependent on the amount of analyte present in 
the sample.  
At 3 nM analyte concentration, the fluorescence in the sample was still detectable by fluorescence 
spectroscopy, however, the desired products were only detected in the sample with 3.3 µM 3-NY by 
full protein mass spectrometry analysis with Q-TOF LC MS. 
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From previous studies with the model peptide FSAY(NO2)LER (4), two major 
dervatized Tyr residue products were expected as observed in the tagging scheme 
presented in Figure 4.5.  Structures of the expected products are shown in Figure 4.3, 
one product containing 2 tagging molecules with a mass addition of 366 amu (atomic 
mass units), confirmed by MS/MS as shown in Figure 4.11 and the other containing 1 
tagging molecule plus an NH2 group with a mass addition of 196 amu also confirmed 
by MS/MS (Figure 4.12).  
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.11 MS/MS of the CaM peptide VFDKDGNGYISAAELR with 2 ABS tag molecules 
(Tyr+366). 
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Figure 4.12 MS/MS of the CaM peptide DGNGYISAAELR with 1 ABS tag molecule and an NH2 
group (Tyr+196). 
 
Through this study with CaM, we have identified a third product from the 
tagging reaction which, in this case turned out to be the major product under the 
reaction conditions used. This product involves an intra-molecular crosslink between 
the derivatized Tyr residue and a neighboring Lys residue, separated by 4 amino acid 
residues, taking the place of the second tagging reagent, or the NH2 group, as 
observed in Figure 4.13. Each step prior to derivatization and the samples after 
derivatization were submitted to full protein MS analysis by Q-TOF MS. Figure 4.14   
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Figure 4.13 CaM peptide VFDKDGNGYISAAELR where Lys 94 was found to cross-link with 
Tyr 99 during fluorescence derivatization with ABS.  
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Figure 4.14 Q-TOF MS of native, nitrated and nitro-reduced CaM prior to derivatization with 
ABS. 
There are 2 Tyr residues present in CaM and each nitration to the Tyr residues is calculated by the 
addition of 45 amu to the molecular weight of native CaM which is 16706.4. Reduction of the nitro-
group in 3-NY to 3-AY was calculated by the addition of 16 amu to the molecular weight of native 
CaM. 
 
 
shows transformed Q-TOF spectra by MassLynx 3.5 for the steps prior to 
derivatization from native to nitrated to nitro-reduced. A representative transformed 
spectra for the tagged sample is shown in Figure 4.15, where the third product was 
observed to be the major one under the reaction conditions with 2 mM ABS that we 
used. The formation of this product was also confirmed by FT-LC MS as shown in 
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Figure 4.16, where we show the doubly charged MS and Figure 4.17, where we show 
the MS/MS identifying the sequence of the derivatized peptide.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15 Representative transformed full protein MS for the sample tagged with 120 molar 
excess of K3Fe(CN)6 and 2 mM ABS. 
We can clearly observe the formation of all three products expected from the fluorescent derivatization 
reaction. (Y+179 for cross-linked, Y+196 for 1ABS molecule+NH2, and Y+366for 2 ABS molecules).  
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Figure 4.16 MS 1 of doubly charged CaM cross-linked peptide VFDKDGNGYISAAELR. 
The actual peak mass for the most abundant peak shown in this spectrum is 967.93, which is 0.1 units 
away from the calculated mass of 968.03. The other peaks on either side represent the isotopic 
distribution of this peak.  
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Figure 4.17 MS/MS of the CaM peptide VFDKDGNGYISAAELR with intra-molecular cross-
link between K94 and Y99 (Tyr+179) after derivatization with ABS. 
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4.5 Discussion/Conclusion 
The data presented in this chapter show that we have successfully applied the 
ABS fluorogenic derivatization of 3-NY to a full protein. We have also shown that 
this derivatization method can be relatively quantitative by fluorescence spectroscopy 
when we tested it with different concentrations of 3-NY in the samples. Formation of 
the desired products (Tyr+196 and Tyr+366) previously shown by studies on model 
peptides and small molecules (2,3) was confirmed by both Q-TOF full protein MS 
and by FT-MS of digested derivatized protein. In addition to the two products 
expected from the reaction, we found that primary amines in proximity to the Tyr of 
interest can participate in the derivatization reaction. In this case, we found that Lys 
94 participated in the tagging reaction of Tyr 99 in CaM, resulting in an intra-
molecular cross-link (Tyr+179). In a more complex system such as whole tissue 
homogenates, the number of products that could form from this derivatization 
reaction will increase significantly since the source of primary amines in more 
complex samples will be orders of magnitude higher than in the current study where 
we only had one protein present in our sample. Therefore, derivatization of full 
proteins is a more fruitful approach in the identification of nitrated proteins by mass 
spectrometry through this method due to the great sample simplification compared to 
working with protein digests. As a result, a key step prior to derivatization would be 
good protein denaturation to increase the accessibility to the residues of interest.  
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5. Fluorogenic derivatization of 3-Nitrotyrosine residues in Calmodulin with  
(3R,4S)-1-(4-(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol 
5.1 List of abbreviations used inside the text 
      - APPD: (3R,4S)-1-(4-(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol 
      - ROS: Reactive oxygen species 
      -     PMA: Phenylmethylamine 
      - RNS: Reactive nitrogen species 
      - CaM: Human Calmodulin, UniProtKB/Swiss-Prot entry P62158, MW      
 16706.4 Da 
      - MeCN: Acetonitrile 
      - K3Fe(CN)6: Potassium Ferricyanide 
      - ABS: 4-aminobenzylbenzene sulfonic acid 
      - 3-NY: Nitrotyrosine 
      - 3-AY: Aminotyrosine 
      - K: Lysine 
      - TNM: Tetranitromethane 
      - ICAT: Isotope-Coded Affinity Tag 
      -     Na2S2O4: Sodium dithionite 
      - NH4HCO3: Ammonium Bicarbonate 
      - K2HPO4: Potassium Phosphate 
    
5.2 Introduction 
In the previous chapter, we have described the fluorogenic derivatization of 
calmodulin (CaM) with a relatively water soluble form of phenylmethiylamine 
(PMA), 4-aminobenzylbenzene sulfonic acid (ABS). We demonstrated that the 
derivatization method works well with our model protein, CaM. To push this 
derivatization method forward and to add new capabilities to the 3-NY specific 
fluorescence derivatization method, a new version of the tag was synthesized by Dr. 
Xiabao Li. This new fluorescent tag is also a derivative of PMA that has the same 
water soluble characteristics as ABS and in addition, it possesses an affinity moiety 
for boronate affinity, (3R,4S)-1-(4-(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol 
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(APPD), shown in Figure 5.1. The boronate affinity packing material was also 
synthesized and the columns were packed in our laboratory by Dr. Xiabao Li (1).  
 
 
Figure 5.1 Chemical Structure of (3R,4S)-1-(4-(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol 
(APPD). 
 
The boronate affinity character of APPD gives the fluorescence derivatization 
technique discussed in Chapter 4, a whole new dimension for derivatized protein 
enrichment and purification. This property will be especially significant when 
working with in-vivo complex samples such as cell lysates and whole tissue 
homogenates.  Being able to single out only derivatized proteins from all other 
proteins present in the samples, will greatly increase sensitivity for mass spectrometry 
analysis. Also, Tyr nitration is a low abundance post-translational modification in-
vivo because nitrated proteins tend to be subjects to proteasomal degradation, or  
repair by a putative denitrase enzyme has been proposed to reverse protein nitration, 
although this path for repair has not been elucidated yet (2). Protein-3-NY in-vivo has 
been reported to be 10-100 pmol/mg, corresponding to only 1 to 5 nitrated Tyr 
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residues in a pool of 10000 (3). Therefore, enrichment through affinity 
chromatography would allow for processing of larger sample volumes to collect and 
analyze only the nitrated and derivatized proteins, diminishing ion suppression by 
higher abundance proteins.  
The boronate affinity chromatographic separation of APPD derivatized 
molecules from non-derivatized molecules is based on the pH dependent formation of 
a pentacyclic complex of boronic acid in the stationary phase with cis-diol on APPD 
(4). However, unlike traditional boronate affinity columns, that require pH values of 9 
or higher for the binding phase and pH of ~4.5 to 5 for eluting, our synthetic column 
works closer to physiological pH for binding (pH 7.5) and pH 2.5 for eluting. 
Originally designed for the purification and enrichment of catechols, which are 
unstable at high pH values (5), working at physiological pH is also good for working 
with biological samples to avoid protein degradation pathways such as deamidation 
that tend to accelerate at high pH (6). 
Another nice characteristic of APPD is that the derivatization experiments can 
be performed in the same way as the experiments for ABS, achieving a selective 
fluorogenic derivatization of nitrotyrosine (3-NY) residues after reduction to 
aminotyrosine (3-AY) and is also amenable for isotopic labeling to obtain isotope 
coded tags for quantitation (7,8).   
In the same manner as ABS, esperiments with APPD were performed on 
calmodulin (CaM), a relatively small 16.7 kDa protein that contains only two Tyr 
residues at positions 99 and 128. As was observed with ABS, experimentation with 
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APPD also yielded  two to three different derivatization products depending on the 
reaction conditions (9); (i) Tyr + 1 APPD (Tyr + 281.1), (ii) Tyr +2 APPD (Tyr 
+536.2) and (iii) Tyr cross-linked with Lys + 1 APPD (Tyr + 264.1). In this study, we 
wanted to test and characterize the affinity properties of APPD as well as the boronate 
affinity column. The tagging reactions were straight forward. However, in these set of 
experiments, instead of testing the effects of iron concentration in the reaction, we 
tested the effects of the concentration of derivatization reagent in the reaction. 
Interestingly, increasing tagging reagent by ten fold in the reaction from 2 mM to 20 
mM, significantly increased the fluorescence in the sample and by boronate affinity 
and full protein mass spectrometry, we were able to characterize the products of the 
tagging reaction. Increasing APPD concentration, increased formation of Tyr 
derivatized with 2 APPD molecules. Also by mass spectrometry, we confirmed that 
the derivatized product with the 2 APPD molecules has the highest affinity to the 
boronate affinity column, and that the intra-molecular cross-linked product has no 
affinity to the Boronate affinity column, probably because its conformation does not 
allow the cis-diol moiety to interact with the column. 
5.3 Experimental 
Materials 
For CaM overexpression, BL21(DE3) cells were purchased from Novagen (La 
Joya, CA). 3-(N-morpholino)propanesulfonic acid (MOPS), M9 media components, 
tetranitromethane (TNM), ethylene diamine tetraacetic acid (EDTA), potassium 
ferricyanide (K3Fe(CN)6), and sodium dithionite (Na2S2O4) were purchased from 
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Sigma-Aldrich (St. Louis, MO). 10DG Desalting columns were purchased from Bio-
Rad (Hercules, CA). Protein assay Bradford Reagents were purchased from PIERCE 
(Rockford, IL). Amicon Ultra-15 centrifugal filter units with Ultracel-3 membranes 
were purchased from Millipore (Billerica, MA). (3R,4S)-1-(4-
(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol (APPD) was synthesized in house 
by Dr. Xiabao Li. De-ionized distilled water was filtered by a Labconco purification 
system (Kansas City, MO). Tris-HCl, potassium phosphate (K2HPO4), HPLC grade 
Acetonitrile (MeCN), sequencing grade trypsin, and phosphoric acid were purchased 
from Fisher Scientific (Pittsburg, PA). 
CaM expression 
CaM overexpression was achieved by transformation of the recombinant 
plasmid containing the gene encoding CaM (generously provided by Eric Gorman 
and Dr. Yunsong Li from the Department of Pharmaceutical Chemistry at the 
University of Kansas) into BL21(DE3) cells (Novagen, La Joya, CA). Transfection 
was done according to the manufacturer’s protocol and overexpression was done at 
37oC in M9 minimal media , essentially following the protocol previously described 
by Li et. al (10). 
CaM purification 
CaM was purified both from transfected (i)BL21(DE3)-T1R competent E. coli 
cells purchased from Sigma (St. Louis, MO) , generously provided by Eric Gorman, 
University of Kansas, and (ii) Novagen BL21(DE3) cells which we transfected in our 
laboratory.  The cells were washed and re-suspended in MOPS buffer prior to lysing 
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them using a French press. The lysed cells were centrifuged and the supernatant was 
collected and loaded onto an ÄKTA FPLC system (Amersham Biosciences, 
Piscataway, NJ) with a pre-equilibrated (50 mM Tris-HCl, pH 7.5, 1mM CaCl2) 
XK26 (26 mm i.d. x 10 cm) column (GE Healthcare Bio-Sciences Corp., Piscataway, 
NJ) packed with Phenyl–Sepharose. After a few washes with equilibration buffer, 
CaM was eluted with 10 mM Tris-HCl, pH 7.5 and 10 mM EDTA. The peak 
containing CaM was collected into ~twelve 1 ml fractions and concentrated using an 
Amicon Ultra-15 centrifugal filter unit with an Ultracel-3 membrane (10,11). At the 
final centrifugation step, the protein was buffer exchanged into 50 mM Tris, pH 8, 
and stored at -80 oC until used. 
CaM Nitration 
A stock solution of TNM was washed by 3 water extractions. Then, an 840 
mM stock solution of TNM in ethanol was prepared and stored at 3 oC. After 
determining protein concentration of the CaM stock solution using the Bradford 
Reagent method, 300 µl of stock protein solution were added to 2700 µl of nitration 
buffer composed of 50 mM Tris, pH 8 and 5 mM CaCl2 (12). For the nitration 
reaction, we calculated 50X molar excess of TNM to tyrosine.  The reaction mixture 
was mixed by rotation for 3 hrs at room temperature. The nitrated protein was then 
cleaned up using a 10DG Desalting column by gravity filtration and at the same time, 
the buffer was exchanged to 50 mM NH4HCO3. Eight 1 ml fractions were collected 
from the desalting column and each one was tested for the presence of nitrated CaM 
by scanning absorbance from 200 to 500 nm using a Cary 50 UV spectrophotometer. 
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Only the fractions giving an absorbance at 280 and ~430 nm were pooled and saved. 
After pooling the fractions, an absorbance scan was performed again to determine the 
3-NY content, by diluting 50 µl of sample in 0.1% NaOH taking into account the 
dilution factor and using the extinction coefficient for 3-NY ɛ=4400 M-1cm-1 (Conc. 
of 3-NY=(Abs at 430nm/4400)x(dilution factor)) (13). Once our 3-NY content was 
established, we measured our total protein concentration in the nitrated sample and 
determined that we had ~2.6 mol 3-NY per mol of CaM.  
CaM 3-NY reduction to 3-AY 
 The first 4 fractions from the 10DG column contained the nitrated protein 
sample in 50 mM NH4HCO3 and were pooled. 200 µl of this sample were saved for 
measuring 3-NY content and the rest were submitted to 3-NY reduction with sodium 
dithionite. A disappearance of the characteristic yellow color from 3-NY was 
observed when the concentration of sodium dithionite was at 300 µM in the reaction. 
3 ml of this sample were cleaned using a new 10DG column and 50 mM NH4HCO3 
as the equilibration buffer. Again, protein was observed to be present in only the first 
4 fractions. These fractions were pooled and a 1.5 ml of this sample was aliquoted for 
solution phase trypsin digestion. 800 µl of this sample was saved for measuring 
protein concentration and the rest was precipitated in excess 100% EtOH at -70oC 
overnight. The precipitated proteins were resolubilized in 100 mM K2HPO4 buffer. 
Protein concentration at all steps was measured by the Bradford reagent method.  
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Tagging Reaction 
CaM Peptides 
The trypsin digested CaM samples were aliquoted into 3 Eppendorf™ tubes, 
each containing 500 µl.  Two were used for tagging and the third was used as one of 
the controls.  
 The samples were set up as follows: 
♦ C1: 250 µM K3Fe(CN)6 + 2 mM APPD + 500 µl 50 mM NH4HCO3 
♦ C2: 250 µM K3Fe(CN)6 + 12.7 µM CaM digest (500 µl) 
♦ C3: 250 µM K3Fe(CN)6 + 20 mM APPD + 500 µl 50 mM NH4HCO3 
♦ C4: 250 µM K3Fe(CN)6 + 2 mM APPD + 12.7 µM CaM digest (500 µl) 
♦ C5: 250 µM K3Fe(CN)6 + 20 mM APPD + 12.7 µM CaM digest (500 µl) 
After adding all tagging components to the tubes, they were rapidly 
centrifuged and incubated at room temperature for 3 hrs before measuring the 
fluorescence spectra for the samples. 
Whole protein labeling 
After nitroreduction, CaM was precipitated in EtOH and resolubilized in 1 ml 
of 100mM K2HPO4. The samples were diluted to give a final concentration of 8 µM 
CaM in the reaction. These samples were labeled simultaneously with the CaM digest 
samples. 
The samples were set up as follows: 
♦ C2: 160 µM K3Fe(CN)6 + 8 µM CaM (500 µl) 
♦ C4: 160 µM K3Fe(CN)6 + 8 µM CaM (500 µl) + 2 mM APPD 
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♦ C5: 160 µM K3Fe(CN)6 + 8 µM CaM (500 µl) + 20 mM APPD 
Controls C1 and C3 for the peptide reaction set were shared with this whole 
protein reaction set. Fluorescence spectra for these samples were also taken after 3 hrs 
of reaction time at room temperature. 
Iron concentrations for these set of reactions were kept at a 10X molar excess 
to 3-NY in the samples since this was the optimal iron concentration found in the 
labeling study of the model peptide FSAY(NO2)LER.  
Fluorescence Characterization 
Fluorescence characterization of each tagged sample was done using a 
fluorescence spectrophotometer (RF 5000U Shimadzu, Japan). Both excitation and 
emission wavelengths were determined using a 400 µl fluorescence quartz cuvette. 
Samples were diluted 10 times in 100 mM phosphate, pH 9 in order to obtain 
readings within the instrument’s data window. Excitation (EX) for APPD labeled 
products was found to be 350-360 nm and the emission (EM) was found to be 500-
515 nm depending on the nature of the analyte. For peptides, the EM was observed to 
have a slight red shift compared to whole protein samples. 
Gel electrophoresis 
Derivatized proteins with different iron concentrations were submitted to 
SDS-PAGE on 4-20 % Tris-HCl pre-cast gels. 25 µl of each sample were diluted with 
2X sample buffer for a total volume of 50 µl. The gel was run at 200 V for 35 
minutes. The gels were removed from their casing and placed under a hand held UV 
lamp, (Model UVL-56 115 V, 60 Hz, 0.16 A, UVP, Inc., San Gabriel, CA 91778). 
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The fluorescent bands were cut out and followed by in-gel trypsin digestion (14). The 
trypsin digests were then submitted for MS/MS analysis. 
In-gel trypsin digestion 
  The excised gel bands were first crushed into smaller pieces and 200 µl of 
pure MeCN were added to dehydrate the gel pieces. Then, 2 µg of trypsin were added 
to each sample in ~ 50 to 60 µl of 50 mM NH4HCO3 and incubated at 37oC overnight. 
The digested protein samples were saved for mass spectrometry analysis with the FT-
ICR mass spectrometer available in the Multidisciplinary Research Building (MRB) 
here at the University of Kansas.  
Boronate Affinity 
The boronate affinity material was synthesized in our laboratory by chemical 
modification of Nucleosil, 5 µm, 500 Å pore size silica gel obtained from Macherey-
Nigel as described in (1) by Dr. Xiabao Li. The silica gel was modified with 4-(3 
butenylsulfonyl) phenylboronic acid, synthesized as shown in the reaction Schemes 1 
and 2 of Li, et. al. (1). In order to functionalize the silica with the synthetic boronic 
acid, the boronic acid was mixed and sonicated with aezotropically dried silica slurry 
for 1 hr, heated to 120oC and refluxed for 24 hrs in a moisture free environment. The 
final boronate affinity functionalized silica was extensively washed with chloroform, 
deionized water and methanol prior to drying it at 120oC. A slurry of the boronate 
affinity functionalized silica was made in acetone and the boronate affinity column 
was packed into a stainless steel column (4.6 i.d x 50 mm) under a pressure of 8000 
psi, using an air driven fluid pump (Haskel) (1). The synthetic boronate affinity 
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column was connected to a Varian (Star 9050) HPLC instrument capable of running a 
3 solvent system, after optimization with the model peptide FSAY(NO2)LER. The 
pump was coupled with a Varian UV detector (Star 9012), set at 214 nm and a 
Shimadzu fluorescence detector (RF-10AXL) set at EX 350 nm and EM 510 nm. The 
injection loop capacity was 100 µl. 
Mobile Phases 
A: 10 mM K2HPO4 in 10% MeCN, pH 7.4 
B: 10 mM K2HPO4 in 50% MeCN, pH 7.4 
C: 0.02% TFA in 50% MeCN, pH 2.5 
Gradient 
The first chromatographic step was done in 100% A for 10 min. Then, the 
gradient was changed from 100% A to 100% B in one min and kept in 100% B for 
another 10 min to wash all unspecific binding since the column was found to have 
affinity and reverse phase characteristics. Finally, for the affinity elution step, the 
mobile phase was changed from 100% B to 100% C in one min and kept at a 100% C 
for 13 min. After every run, the column was equilibrated back to 100% A at least for 
10 min. 
Mass Spectrometry Analysis 
Full protein MS analysis was performed on a Q-TOF-LCMS instrument by Dr. 
Todd Williams and Mr. Bob Drake at the University of Kansas Mass Spectrometry 
Lab. The samples were desalted just prior to mass spec analysis with a reversed phase 
C4 column. The MS data analysis was done using Mass-Lynx 3.5 software 
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(Micromass, UK). The multiply charged spectrum obtained from the mass 
spectrometer was transformed to a full protein, uncharged spectrum using this 
software. This full protein spectrum was used for analysis of full protein 
derivatization data. 
Peptide MS/MS were performed on an LTQ-FT hybrid linear quadrupole ion 
trap Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer 
(ThermoFinnigan, Bremen, Germany) via capillary liquid chromatography by Dr. 
Nadezhda Galeva at the University of Kansas.  Prior to MS and MS/MS analysis, 
peptides were separated by reversed phase chromatography. The raw acquisition data 
was processed by BioWorks 2.2 software (Thermo Scientific, Waltham, MA) 
followed by peptide/protein identification using Sequest (Thermo Finnigan) and 
Mascot (Matrix Science, Boston, MA) and X!Tandem (The Global Proteome 
Machine Organization) database-searching programs. The MS/MS spectra were then 
validated by Scaffold 1.7 (Proteome Software Inc., Portland Oregon), a software that 
operates on a statistical method by setting confidence thresholds to the data obtained.  
5.4 Results/Discussion 
We followed the same tagging method as for ABS, discussed in Chapter 4. 
We found that APPD basically behaves in the same way as ABS, however, the 
emission wavelength is slightly red shifted in comparison to ABS and appears at 510 
nm (Figure 5.2). For these sets of experiments with APPD, CaM nitration and nitro-
reduction prior to derivatization was also monitored by full protein Q-TOF analysis. 
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Figure 5.3 shows the full MS for nitrated CaM and Figure 5.4 shows the full protein 
MS for nitro-reduced CaM with sodium dithionite. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Emission spectra for derivatized CaM. 
Two different concentrations of tagging reagent in the reaction were tested, 2 mM APPD (-----) and 20 
mM APPD (____). Derivatization with 2 mM APPD yielded at least 2 different products with different 
fluorescent properties.  
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Figure 5.3 Full protein MassLynx transformed MS spectrum for nitrated CaM. 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Full protein MassLynxs transformed MS spectrum for nitro-reduced CaM. 
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As with ABS, proteins tagged with APPD can also be fractionated on a gel 
after the tagging reaction, or after affinity chromatography for further separation and 
purification. Prior to having the affinity chromatography worked out, we tagged CaM 
with 2 mM APPD and different iron concentration ranging from 9X to 100X molar 
excess to 3-NY. We ran these tagged CaM samples on an SDS-PAGE gel (Figure 5.5) 
and submitted the in-gel digests for mass spectrometry analysis on the FT-ICR-MS. 
From these in-gel digests, we identified peptides tagged with one and two APPD 
molecules. Confirmation of the tagging reaction was obtained by MS/MS evidence 
for the desired products; with one APPD tag, shown in Figure 5.6 and the desired 
product with two APPD tags,shown in Figure 5.7. Finding these products by MS/MS 
also confirmed that the tagging reaction with APPD followed the same pattern as the 
reaction with the ABS tagging reagent discussed in the previous chapter. 
 
Figure 5.5 SDS-PAGE gel of APPD tagged CaM samples with different iron concentrations. 
Fluorescent bands were excised, and subjected to in-gel protein trypsin digestion. Digested proteins 
were then submitted for FT-ICR MS analysis. 
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Figure 5.6 MS/MS spectrum from the CaM APPD tagged and in-gel trypsin digested sample 
with 1 APPD molecule + NH2.  
The peptide sequence covered by this spectrum is DGNGY(1APPD/NH2)ISAAELR, where the mass 
modification in Y+281.1.  
 
 
 
 
 
 
 
 
 
Figure 5.7 MS/MS spectrum from the CaM APPD tagged and in-gel trypsin digested sample 
with 2 APPD molecules.  
The peptide sequence covered by this spectrum is EADIDGDGQVNY(2 APPD)EEFVQMMTAK 
where the mass modification is Y+536.2. 
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For the boronate affinity step, several synthetic boronate affinity columns 
were tested with no successful results of retention of desired products. Finally, we 
decided to go back to the model peptide FSAY(NO2)LER and test the affinity 
chromatography on this simpler system (details on this experiments can be found in 
Appendix 1). Through this studies, we found the column was bimodal, it had both 
reversed phase chromatography and affinity chromatography properties. This led us 
to test several chromatographic conditions and finally, we arrived at the three mobile 
phase system, where we have three steps in the affinity chromatography, a binding 
step done in mostly aqueous conditions and pH 7.5, a washing step done at higher 
organic content and pH7.5, and finally an elution step where we kept the organic 
content the same as the wash step but decreased the pH to 2.5 to break the affinity 
bonds as well. 
After optimizing conditions for boronate affinity chromatography, CaM 
samples were processed and derivatized as described in the experimental section. The 
effect of adding a ten-fold higher excess of tagging reagent than what had been used, 
from 2 mM to 20 mM was tested. This was done to see if we could increase formation 
of the desired product and decrease the formation of the cross-linked product and 
other undesirable products. We observed that fluorescence was higher for tagging 
reactions with 20 mM APPD, which in turn, exhibited higher affinity retention for the 
derivatized products during boronate affinity chromatography, compared to tagging 
reactions with 2 mM APPD (Figure 5.8). The peaks eluted during the washing step 
and elution step were collected separately for both samples, concentrated by centri-
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vap (LABCONCO, Kansas City, MO) and analyzed by Q-TOF full protein mass 
spectrometry.  
 
 
 
 
 
 
 
Figure 5.8 APPD derivatized full protein CaM boronate affinity chromatogram with 
fluorescence detection.  
The binding step goes from 0-10 min (pH 7.5), washing step goes from 11-21 min (pH 7.5) and the 
elution step goes from 22-35 min (pH 2.5). Here we tested two derivatization conditions, 2 mM APPD 
and 20 mM APPD, keeping iron constant to 30X molar excess to 3-NY.  
 
By mass spectrometry analysis, peak one (washing step) contained the 
products that bound to the column by reversed phase but no affinity. After careful 
manual evaluation of the transformed spectra by the software MassLynx, we 
confirmed that these products included the Lys-Tyr cross-linked product, and the 
product with only one tag molecule plus an NH2 group for both reaction conditions of 
2 mM APPD (Figure 5.9) and 20 mM APPD (Figure 5.10). Peak two (elution step) on 
the other hand, contained mainly the product with the two taggging molecules also for 
both 2 mM APPD (Figure 5.12) and 20 mM APPD (Figure 5.12).  
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Figure 5.9 Q-TOF MassLynx transformed MS spectrum for Peak 1 of CaM tagged with 2 mM APPD.
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Figure 5.10 Q-TOF MassLynx transformed MS spectrum for Peak 1 of CaM tagged with 20 mM APPD. 
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Figure 5.11 Q-TOF MassLynx transformed MS spectrum for Peak 2 of CaM tagged with 2 mM APPD. 
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Figure 5.12 Q-TOF MassLynx transformed MS spectrum for Peak 2 of CaM tagged with 20 mM APPD.
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It is intuitive to understand why the Lys-Tyr cross-linked product did not have 
any affinity to the boronate affinity column. For instance, the cis-diol group in the 
tagged molecule may not have been accessible for affinity due to the cyclic nature in 
this region. The cross-link may have caused the protein to fold differently on itself, 
making the cis-diol moiety unavailable for interaction with the column. In addition, 
only one cis-diol moiety seems to provide some interaction with the column, but not 
strong enough for complete retention by affinity since this product was mainly 
identified in sample collected during the washing step by full protein MS. This 
conclusion was drawn because even without cross-linking, the product with only one 
tag molecule plus an NH2 group was also found in the wash peak.  
Trypsin-digested CaM was submitted to the same reaction conditions as full 
protein CaM. Judging from the affinity chromatography chromatogram and 
fluorescence detection, there were a lot more undesirable products formed because we 
had elution at all three steps, of binding, washing and eluting, Figure 5.13. The peaks 
appearing at these three time points were collected and submitted for MS analysis 
with the FT-ICR-MS. Unfortunately, no useful data was obtained from the mass 
spectrometry experiments, confirming that reactions done on complex protein digest 
systems, increases the number of different unknown products formed from the 
derivatiation reaction, making the identification of 3-NY containing proteins and 
peptides not possible by this method.    
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Figure 5.13 Boronate affinity chromatogram of APPD derivatized CaM peptides, with 
fluorescence detection.  
The binding step goes from 0-10 min (pH 7.5), washing step goes from 11-21 min (pH 7.5) and the 
elution step goes from 22-35 min (pH 2.5). Here we tested two derivatization conditions, 2 mM APPD 
and 20 mM APPD, keeping iron constant to 30X molar excess to 3-NY.  
 
5.5 Conclusion 
Through the experiments carried out for this chapter, we characterized the 
column as bimodal, having both reversed phase characteristics, as well as affinity 
characteristics. Derivatization was found to yield higher percentage of desired 
products when the concentration of tagging reagent was increased. Affinity by the 
synthetic column was confirmed to be only for the derivatized product containing two 
APPD molecules. And finally, we also confirmed that fluorescent tagging is very 
efficient when 3-AY is readily accessible to the tagging reagents, however, in order to 
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be able to identify derivatized products by mass spectrometry, derivatization needs to 
be done in simpler systems (full proteins), rather than peptides due to the higher 
possibilities of primary amines in the latter.  
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6. Conclusion and Future Directions 
 In the present study we have presented different proteomics tools applied to 
the study of protein Tyr nitration, especially the new tagging technique developed by 
our group and Dr. Stobaugh’s group. In-vitro studies were performed on creatine 
kinase, where we observed a major loss of activity due to protein oxidation with 
peroxynitrite. In-vivo studies as a function of aging were performed on rat cardiac 
muscle proteins, and we observed that there is an increased accumulation of nitrated 
proteins with aging, and discovered that a few of these proteins are part of the 
cytoskeleton, which may help understand tissue and organ function deterioration with 
aging. In order to characterize and demonstrate the characteristics of the new 3-NY 
specific tagging technique, model protein studies have been performed on calmodulin 
(CaM), a relatively small and simple model protein that contains only two Tyr 
residues. The tagging technique has been shown to be very efficient when applied to  
a full protein and its fluorescent properties have been shown to correlate well with the 
amount of analyte presence in the samples for both versions of the tag, ABS and 
APPD.  
 During the in-vivo studies of cardiac protein nitration as a function of aging in 
Chapter 3, several proteins of interest were identified, among them, cytoskeletal 
proteins such as myosin, nebulin-related anchoring protein and tropomyosin, and 
proteins specifically related to disease such as neurofibromin. Isolation of these 
proteins and studying them at the individual level would be interesting to determine 
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whether protein nitration is the cause of the hypothesized loss of function and thus 
muscle deterioration, or an effect from disease or aging.    
 Then, in chapters 4 and 5, we characterized the tagging technique for both 
ABS and APPD. The next essential step in this study would be to further characterize 
the quantitative capabilities of the tagging method by repeating experiments using 
isotopically labeled tags. This could be accomplished by having a CaM sample 
nitrated and nitro-reduced. Then, dividing this sample into two equal volumes and 
tagging them simultaneously, one with a heavy (deuterium) tag, and the other one a 
light (hydrogen) tag and finally, combining these samples just prior to mass 
spectrometry analysis. Mass spec analysis would show two different signals with the 
same intensity for the light and heavy tags. The place for the isotopic labels on ABS 
and APPD are shown on Figure 1. Both fluorescent tags allow for the incorporation  
 
Figure 6.1 ABS and APPD fluorescent tags with isotopic labels for relative quantitation by mass 
spectrometry analysis.  
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four deuteriums (D) per tag molecule leading to a mass difference of 4 in the case of 
derivatization products with one tag incorporated and a mass difference of 8 in the 
case of incorporation of two tagging molecules during derivatization, as shown in 
Chapters 4 and 5 for ABS and APPD respectively.  
 In the case of APPD, boronate affinity chromatography is a good tool for 
tagged protein enrichment and this would greatly improve results by helping to 
overcome the problems that are encountered due to the low abundance of nitrated 
proteins in complex mixtures such as tissue homogenates when doing in-vivo studies. 
In combination with fluorescence detection, boronate affinity chromatography would 
be a good source of relative quantitation since the fluorescence intensity in the 
samples is directly proportional to the amount of analyte present in the sample, and 
these results could be also confirmed by use of isotopically labeled tagging reagents 
and mass spectrometry analysis. 
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Appendix 1: Boronate Affinity column characterization with model peptide 
FSAY(NO2)LER  
1. List of abbreviations used inside the text 
      - APPD: (3R,4S)-1-(4-(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol 
      - ROS: Reactive oxygen species 
      - RNS: Reactive nitrogen species 
      - MeCN: Acetonitrile 
      - K3Fe(CN)6: Potassium Ferricyanide 
      - 3-NY: Nitrotyrosine 
      - 3-AY: Aminotyrosine 
      - ICAT: Isotope-Coded Affinity Tag 
      -     Na2S2O4: Sodium dithionite 
      - FSAY(NO2)LER: Synthetic model peptide 
      - K2HPO4: Potassium Phosphate 
 
2. Introduction 
The boronate affinity chromatography system was synthesized in house by Dr. 
Xiabao Li and its properties were not well understood. Boronate affinity 
chromatography data obtained from complex sample mixtures such as cell lysates, 
full proteins and protein digests was not reproducible. In addition, complete retention 
with very little elution was observed for a purely aqueous system and very little 
retention to no retention was observed when high levels of organic solvents (50% 
MeCN) were added to the mobile phase. As a result, we needed a simpler system to 
characterize the boronate affinity column as well as the affinity (APPD) labeling 
conditions to elucidate optimal conditions. Therefore, since extensive work had been 
done previously on the synthetic peptide FSAY(NO2)LER for the characterization of 
the ABS fluorescent label, we picked the same peptide for the characterization of 
APPD fluorescent affinity labeling and the boronate affinity purification.   
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3. Experimental 
Materials 
Potassium ferricyanide (K3Fe(CN)6), and sodium dithionite (Na2S2O4) were 
purchased from Sigma-Aldrich (St. Louis, MO). Oasis HLB reverse phase solid phase 
extraction cartriges were purchased from Waters (Milford, MA). (3R,4S)-1-(4-
(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol (APPD) was synthesized in house 
by Dr. Xiabao Li. De-ionized distilled water was filtered by a Labconco purification 
system (Kansas City, MO). Potassium phosphate (K2HPO4), HPLC grade Acetonitrile 
(MeCN),  and phosphoric acid were purchased from Fisher Scientific (Pittsburg, PA). 
FSAY(NO2)LER 3-NY reduction to 3-AY 
A 1 mg/ml solution of FSAY(NO2)LER (1 mM) was prepared in 100 mM 
Phosphate buffer at pH 9. This solution was very yellow because of the presence of 
large amounts of 3-NY in the sample. Then, from this solution, a 100 µM solution of 
FSAY(NO2)LER by taking 100 µl of 1 mM FSAY(NO2)LER and adding 900 µl of 10 
mM Na2S2O4 in 50 mM phosphate buffer at pH 4.5. The color immediately 
disappeared and the solution turned clear, indicating the reduction of 3-NY to 3-AY. 
The reduced peptides were cleaned with Oasis HLB cartriges by centrifugation 
following the manufacturer’s protocol. The final elution step was in 100% MeOH so 
the peptides were dried down with a centrivap (Labconco, Kansas City, MO) and 
resolubilized in 100 mM phosphate buffer at pH 9.  At this step, no peptide loss was 
assumed when proceeding to the next step.  
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Tagging Reaction 
FSAY(NO2)LER peptide samples 
The reduced peptide samples were aliquoted into 3 eppendorf tubes, each 
containing 500 µl.  Two were used for tagging and the third was used as one of the 
controls.  
 The samples were set up as follows: 
♦ C1: 100 µM K3Fe(CN)6 + 500 µl 100 mM K2HPO4 
♦ C2: 100 µM K3Fe(CN)6 + 10 µM FSAY(NO2)LER in 100 mM K2HPO4 
(500 µl) 
♦ C3: 100 µM K3Fe(CN)6 + 2 mM APPD + 100 mM K2HPO4 
♦ C4: 100 µM K3Fe(CN)6 + 2 mM APPD + 10 µM FSAY(NO2)LER in 100 
mM K2HPO4 (500 µl) 
♦ C5: 100 µM K3Fe(CN)6 + 20 mM APPD + 10 µM FSAY(NO2)LER in 100 
mM K2HPO4 (500 µl) 
After adding all tagging components to the tubes, they were rapidly 
centrifuged and incubated at room temperature for 2.5 hrs before measuring the 
fluorescence spectra for the samples. 
Fluorescence Characterization 
Fluorescence characterization of each tagged sample was done using a 
fluorescence spectrophotometer (RF 5000U Shimadzu, Japan). Both excitation and 
emission wavelengths were determined using a 400 µl fluorescence quartz cuvette. 
Samples were diluted 10 times in 100 mM Phosphate, pH 9 in order to obtain 
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readings within the instrument’s data window. Excitation (EX) for APPD labeled 
products was found to be 350-360 nm and the emission (EM) was found to be 500-
515 nm depending on the nature of the analyte. For peptides, the EM was observed to 
have a slight red shift compared to whole protein samples. 
Boronate Affinity 
The boronate affinity material was synthesized in our laboratory by chemical 
modification of Nucleosil, 5 µm, 500 Å pore size silica gel obtained from Macherey-
Nigel as described in (1) by Dr. Xiabao Li. The silica gel was modified with 4-(3 
butenylsulfonyl) phenylboronic acid, synthesized as shown in the reaction Schemes 1 
and 2 of Li, et. al. (1). In order to functionalize the silica with the synthetic boronic 
acid, the boronic acid was mixed and sonicated with aezotropically dried silica slurry 
for 1 hr, heated to 120oC and refluxed for 24 hrs in a moisture free environment. The 
final boronate affinity functionalized silica was extensively washed with chloroform, 
deionized water and methanol prior to drying it at 120oC. A slurry of the boronate 
affinity functionalized silica was made in acetone and the boronate affinity column 
was packed into a stainless steel column (4.6 i.d x 50 mm) under a pressure of 8000 
psi, using an air driven fluid pump (Haskel) (1). The synthetic boronate affinity 
column was tested in two different HPLC systems. First, it was tested on a Shimadzu 
HPLC system composed of two pumps (LC-10AS) controlled by the system 
controller (SCL-10A). Both UV (SPD-10AV) and fluorescence (RF-10AXL) 
detection were used. In this system, column properties were tested both in purely 
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aqueous conditions and also in the presence of 50 % MeCN with changing pH for 
binding and elution phases. The sample loop capacity was 20 µl. 
Mobile Phases Aqueous Conditions 
A: 50 mM Na2HPO4, pH 7.4 
B: 0.02% TFA, pH 2.5 
Mobile Phases Organic Conditions 
A: 50 mM Na2HPO4 in 50 % MeCN, pH 7.4 
B: 0.02% TFA, in 50% MeCN, pH 2.5 
Gradient 
The first chromatographic step was done in 100% A for 10 min for binding. 
Then, the gradient was changed from 100% A to 100% B in one min and kept in 
100% B for another 15 min for the affinity elution step. After every run, the column 
was equilibrated back to 100% A at least for 10 min.  
Then, we switched to a Varian (Star 9050) HPLC instrument capable of 
running a 3 solvent system. The pump was coupled with a Varian UV detector (Star 
9012), set at 214 nm and a Shimadzu fluorescence detector (RF-10AXL) set at EX 
350 nm and EM 510 nm. 
Mobile Phases 
A: 10 mM K2HPO4 in 10% MeCN, pH 7.4 
B: 10 mM K2HPO4 in 50% MeCN, pH 7.4 
C: 0.02% TFA in 50% MeCN, pH 2.5 
 126 
Gradient 
The first chromatographic step was done in 100% A for 10 min. Then, the 
gradient was changed from 100% A to 100% B in one min and kept in 100% B for 
another 10 min to wash all unspecific binding since the column was found to have 
affinity and reverse phase characteristics. Finally, for the affinity elution step, the 
mobile phase was changed from 100% B to 100% C in one min and kept at a 100% C 
for 13 min. After every run, the column was equilibrated back to 100% A at least for 
10 min. 
4. Results/Discussion 
Exitation and Emission properties of the derivatized samples were measured 
by a fluorescence spectrophotometer. Interestingly, two different EM wavelengths 
were present when we used 2 mM APPD in the derivatization reaction, at 425 nm and 
510 nm. However, when we increased the APPD concentration to 20 mM, only one 
EM wavelength at 510 nm was present (Figure 1). From previous experiments with 
APPD in full proteins and protein digests, the target wavelength for desired products 
was observed to be 510 nm, confirming that higher concentrations of derivatization 
reagent increases the yields for the desired products. 
Then, these samples were injected onto the synthetic boronate affinity column. 
Affinity conditions were tested both in purely aqueous conditions and 50% MeCN 
conditions separately. The binding mobile phase was at pH 7.5 and elution mobile 
phase was at pH 2.5.  For aqueous conditions, both mobile phases were made in DD 
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H2O and for 50%  MeCN, we added 50% MeCN to both binding and elution mobile 
phases, keeping the ionic strength of the buffers constant. 
 
 
 
 
 
 
 
Figure 1 Emission spectra for FSAYLER. 
Samples derivatized with 2 mM APPD (---) and 20 mM APPD (___). 
 
From these experiments, we found that there was high retention in aqueous 
conditions, but almost no elution, even when the pH conditions for elution were met. 
Then, when we tested the same sample in 50% MeCN conditions, we observed low 
binding and high percentage of elution in both the binding phase and the elution 
phase. Figure 2 shows the boronate affinity chromatograms for derivatized 
FSAYLER in both aqueous and 50% MeCN. Results from these experiments helped 
us to understand that the column was bimodal, it possessed both reversed phase 
characteristics as well as affinity properties. Therefore, we decided to move to a 3 
mobile phase system where we could take advantage of both properties of the column. 
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Figure 2 Boronate Affinity 
chromatograms for derivatized 
FSAYLER. 
(A) 50% MeCN mobile phases and (B) 
100% aqueous conditions. For both 
conditions, the binding aqueous phase is 50 
mM phosphate (pH 7.5) and goes from 0 to 
10 min. Elution aqueous phase is 0.02% 
TFA (pH 2.5) and goes from 11 to 25 
minutes. 
 
In our 3 mobile phase system, we introduced a binding phase with low MeCN 
content (10%), pH7.5, and we used the 50% MeCN mobile phase at pH 7.5 as the 
washing step to wash off all unspecific binding to the column by the reversed phase 
mechanism. Finally, we kept the elution mobile phase at 50% MeCN and pH 2.5. The 
reversed phase mechanism helped the compounds stick to the column longer for the 
binding to occur, and the washing step ensured that all compounds bound to the 
column only by hydrophobic interactions were washed away. Finally, the desired 
compounds with affinity to the boronate affinity were eluted by lowering the pH. As a 
result, this affinity column can be used as an enrichment method for APPD tagged 
compounds, over several injections if sample volume is high. Figure 3 shows the 
boronate affinity chromatogram for FSAYLER using this three mobile phase system 
for both, samples tagged with 2 mM APPD and 20 mM APPD. As predicted from the 
0 5 10 15 20 25
0 5 10 15 20 25
Time (min)
Time (min)
A: 50% MeCN in mobile phases
B: 100% Aqueous mobile phases
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fluorescence spectra for both samples where samples derivatized with 2 mM APPD 
showed the presence of different products with different fluorescent properties, more 
products were found in the wash step and less in the elution step, when compared to 
the chromatogram of the samples derivatized with 20 mM APPD.   
In conclusion, we achieved a good system for affinity enrichment and we 
were also able to elucidate that high concentrations of the affinity tag compound 
APPD are necessary for the formation of our desired products.  
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Figure 3 Boronate affinity chromatography with 3 mobile phases. 
Binding: 0 to 10 min (10 % MeCN, pH 7.5), washing: 11 to 21 min (50 % MeCN, pH 7.5), and 
eluting: 22 to 35 min (50 % MeCN, pH 2.5). Here, we also compare affinity for samples tagged with 2 
mM APPD (red) and 20 mM APPD (black).  
 
